Ballot Facsimile Transmittal · Ballot Facsimile Transmittal ... SOT Ballot Clerk Company: Dembo...

Ballot Facsimile Transmittal

Please Deliver Immediately

To: Tiwana Clark, SOT Ballot Clerk Company: Dembo Jones

Phone: 301.770.5100 Fax: 301.770.5202

From: Date:

Phone: Very Important: Ballot Reply

Only Ballots faxed by February 1, 2018 will be counted.

Please fax this page and the Ballot Card to 301.770.5202.Ballot cards faxed to SOT will not be counted.

The following must be completed:

___________________________ Signature

___________________________ Printed Name

___________________________

___________________________

___________________________Address

11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191Telephone: 703.438.3115 Fax: 703.438.3113 Email: [email protected]

www.toxicology.org

Please Deliver Immediately

Ballots must be returned with the Ballot transmittal cover page and faxed to Dembo Jones 301.770.5202.

Society of ToxicologyOfficial Ballot 2018–2019

(Nominees are listed by office, in reverse alphabetical order.)

Ballot Card

11190 Sunrise Valley Drive, Suite 300, Reston, Virginia 20191Telephone: 703.438.3115 Fax: 703.438.3113 Email: [email protected]

www.toxicology.org

Only Ballots faxed by February 1, 2018 will be counted.

Vice President-Elect (Vote for only one)

{{ George P. Daston{{ Susan J. Borghoff{{ ____________________________

Treasurer-Elect(Vote for only one)

{{ Craig Rowlands{{ Anthony M. Ndifor{{ ____________________________

Councilors (Vote for no more than two)

{{ Courtney E. W. Sulentic{{ Vicente Santa Cruz{{ Barbra L. F. Kaplan{{ Matthew J. Campen{{ ____________________________

Awards Committee (Vote for no more than three)

{{ Yvonne Will{{ Robert A. Roth{{ Kenneth E. McMartin{{ J. Eric McDuffie{{ Susan C. Hester{{ Nancy D. Claude{{ ____________________________

Membership Committee (Vote for no more than three)

{{ Sharmilee P. Sawant{{ Terrence J. Monks{{ Joel N. Meyer{{ Shaun D. McCullough{{ Flemming R. Cassee{{ Antonio T. Baines{{ ____________________________

Nominating Committee—From the Membership-at-Large (Vote for only one)

{{ Bob van de Water{{ Gary O. Rankin{{ Augustine Arukwe{{ ____________________________

Nominating Committee—From Regional Chapters (Vote for only one)

{{ Seema Somji{{ Laura M. Plunkett{{ Tim R. Nurkiewicz{{ Baitang Ning{{ Whitney V. Christian{{ ____________________________

Nominating Committee—From Specialty Sections (Vote for no more than two)

{{ Judith T. Zelikoff{{ Caren M. Villano{{ Robert L. Tanguay{{ Amy L. Roe{{ Mansi Krishan{{ Rebecca C. Fry{{ John “Jack” R. Fowle, III{{ Joan M. Cranmer{{ Krishna P. Allamneni{{ ____________________________

The following must be completed:

___________________________ Signature

___________________________ Printed Name

___________________________

___________________________

___________________________Address

Biographical Sketches for 2018–2019 Election11190 Sunrise Valley Drive, Suite 300, Reston, VA 20191Creating a Safer and Healthier Worldby Advancing the Science of Toxicology

1

Vice President-Elect (Vote for one of two)

Nominees listed in reverse alphabetical order.

SOT-Elected Positions: Councilor 2001–2003; Treasurer-Elect 2014–2015, Treasurer 2015–2017.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: ATSDR/NCEH/CDC Government Liaison Group 2014–2015; Audit Committee 2008–2011, Chair 2010–2011; Awards Committee 1999–2001; CCT Organizing Committee for Building for Better Decisions 2011–2013; CCT Organizing Committee for FutureTox 2011–2013; CCT Organizing Committee for FutureTox III: Bridges for Translation Council Contact 2014–2016; Committee on Contemporary Concepts in Toxicology 2001–2003; Communications Committee 2013–2014; Congressional Science Fellowship Review Subcommittee 2002–2003; Council Subcommittee for Non SOT Meeting Sponsorship 2001–2002; Council Subcommittee for Non SOT Meeting Funding 2014–2017, Co-Chair 2014–2015, Council Contact and Chair 2015–2017; Endowment Fund Board 2014–present, Ex-Officio Member 2014–2016; Finance Committee 2014–2017, Co-Chair 2014–2015, Council Contact and Chair 2015–2017; K–12 Subcommittee 2002–2003; Liaison Task Force Chair 2004–2005; Placement Committee 1996–1999; Program Committee Ad Hoc Member 1995–1999; Regulatory Affairs and Legislative Assistance Committee 2001–2003; Risk Assessment Task Force 1996–1999; ToxExpo Liaison Working Group 2014–2017, Co-Council Contact 2014–2015, Council Contact 2015–2017; Toxicological Sciences Associate Editor 1997–2002; Toxicology Specialist 1998–1999, 2002–2003; Ohio Valley Regional Chapter 2002–present; Reproductive and Developmental Toxicology Specialty Section 1985–present, Vice President-Elect 1992–1993, Vice President 1993–1994, President 1994–1995, Past President and Councilor 1995–1996; Board of Publications Award 2010; Reproductive & Developmental Toxicology Specialty Section Scientific Achievement Award 2014.

Experience: Dr. Daston has been a toxicologist at Procter & Gamble since 1985. He is a Victor Mills Society Research Fellow, the highest rank on the company’s scientific career ladder. He has an active research program developing methods to predict toxicity using cheminformatics and biotechnology (especially gene expression analysis). His lab also conducts research in mechanistic toxicology and was responsible for identifying the causative agents in a massive pet food (in North America) and infant formula (in China) contamination. Dr. Daston has been active in improving risk assessment and was an author of the recent “Risk 21” report from the National Academy of Sciences. He has co-authored more than 130 papers, co-edited five books and has an h-index of 42.

Dr. Daston began his career as a postdoctoral fellow in Bob Kavlock’s lab at the US EPA’s facility in Research Triangle Park. He did research on functional teratology, juvenile toxicity, and the application of rodent embryo culture to developmental toxicology. After his postdoctoral fellowship, Dr. Daston was an Assistant Professor of Biological Sciences at University of Wisconsin-Milwaukee before joining P&G in 1985. He did a sabbatical at the Salk Institute, in the Molecular Neurobiology lab, in 1993–1994. He has been a Volunteer Professor of Pediatrics at the Cincinnati Children’s Hospital Research Foundation and University of Cincinnati School of Medicine since 1989, as well as an associate faculty member in the program’s NIEHS Teratology Training Grant. He was elected a Fellow of the American Association for the Advancement of Science in 1999.

Dr. Daston has served on the National Academy of Sciences Board on Environmental Studies and Toxicology, as well as several NAS committees that authored reports on toxicology and risk assessment. He has served on the US EPA’s Science Advisory Board, Board of Scientific Counselors, and Endocrine Disrupter Screening and Testing Advisory Committee; the National Toxicology Program’s Board of Scientific Counselors; the National Children’s Study Advisory Committee, and many others. He is a Past President of the Teratology Society, as well as the founding editor of Birth Defects Research: Developmental and Reproductive Toxicology, an official journal of that society. He has been an Associate Editor of Toxicological Sciences, and on the editorial board of Toxicology, Human and Ecological Risk Assessment, Fundamental and Applied Toxicology, and Reproductive Toxicology.

Goals for SOT: SOT is a success story: We have vibrant annual meetings, extensive educational and career development programs, and the science generated by our members has a real impact on public health. At the same time, there are emerging challenges to SOT and our field. For SOT, the challenges include decreased growth of membership and Annual Meeting attendance and increased competition from other journals for the best papers. For the field, we continue to face challenges in research funding and in justifying the relevance of our research.

George P. Daston PhD

Employer Procter & Gamble Company

Year Joined SOT 1985

Education University of Miami, PhD, Developmental Biology, 1981; University of Miami, BS, Biology, 1978.

2

My goal is to confront these challenges by building on SOT’s successes. While we all know that toxicology serves as the foundation for public health decisions about drug and chemical safety, there is insufficient realization from other branches of science of the crucial role toxicology plays in protecting people from diseases that have an environmental etiology. One way to address this problem is outreach to other societies that look at environmental health from a clinical or epidemiological perspective. We can do this by continuing to hold sessions with translational components at our Annual Meeting, and to share content from our meeting with clinical and epidemiology societies. I will also encourage CCT meetings that are jointly sponsored by SOT and clinical societies.

Toxicology has much to offer in thinking about problems in a systems biology way. From our inception, SOT has served as a forum for a unique blend of research approaches, from biochemistry to physiology to pathology to computational modeling, and much, much more. We have much to offer the rest of the life science universe as it converges on systems-level approaches that we are already familiar with. As part of the SOT leadership, I will make sure that we get the most out of our interaction with FASEB, as well as other broad-based organizations like AAAS, with the aim of increasing the appreciation for the contributions being made by toxicology. My goal will be to make sure that we maximize the effectiveness of our outreach.

SOT has played a significant role in education and training. My aim will be to ensure that our training programs remain strong, and to support participation at annual and regional meetings from a large number of students from diverse backgrounds. Many of us, including me, started attending SOT meetings when we were graduate students. Participation in the meeting was instrumental in my decision to have a career in toxicology, and I imagine it still is for students now.

Vice President-Elect (Vote for one of two)

3

Susan J. Borghoff PhD, DABT

Employer ToxStrategies Inc.


Education Chemical Industry Institute of Toxicology (CIIT), Postdoctoral Fellow, 1989; University of North Carolina, Chapel Hill, PhD, Environmental Sciences & Engineering, 1987: University of North Carolina, Chapel Hill, MSPH, Environmental Sciences & Engineering, 1984; East Stroudsburg University, BS, Chemistry, 1980.

SOT-Elected Positions: Awards Committee 2002–2004; Councilor 2009–2011; Education Liaison 2006–2007.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Audit Committee 2015–present, Co-Chair 2015–2016, Chair 2016–2017; Toxic Substances Control Act Task Force 2013–2017; Role of Government in Science Regulation Issue Statement Writer 2015; ATSDR/NCEH/CDC Government Liaison Group 2010–2011; Council Subcommittee on SOT Affiliates and Sponsors Chair 2010–2011; Data Task Force Council Contact 2010–2011; NICHD Government Liaison Group Co-Chair 2010–2012, Chair 2010–2011; Membership Committee Council Contact 2009–2011; Committee on Diversity Initiatives Council Contact 2009–2011; Council Subcommittee for Non-SOT Meeting Funding 2009–2011; Council Subcommittee on Social Networking Chair 2009–2011; Education Committee 2005–2008; Program Committee 2001–2004, Ad Hoc Member 2000–2001; North Carolina Regional Chapter 1996–present, Councilor 1996–1997; Regional Chapter Contact for K–12 Education, 2000–2003; SIG Collaboration Group Council Contact 2010–2011; Hispanic Organization of Toxicologists Special Interest Group 2012–2013; Biological Modeling Specialty Section 2000–2014, Secretary/Treasurer 2002–2004; Biotechnology Specialty Section 2014–2017; Mechanisms Specialty Section 1986–2012; Nanotoxicology Specialty Section 2007–2008; Regulatory and Safety Specialty Section 2013–present; Reproductive and Developmental Toxicology Specialty Section 1986–present; Risk Assessment Specialty Section 2007–present; Frank R. Blood Award 1994.

Experience: Dr. Borghoff has been an active member of SOT for more than 30 years and is currently a Senior Managing Scientist with ToxStrategies Inc., a scientific consulting firm. She began her career as a research technician in the Department of Endocrinology at Albert Einstein School of Medicine and conducted her graduate research at NIEHS, followed by a postdoctoral fellowship at the Chemical Industry Institute of Toxicology (CIIT). Dr. Borghoff continued at CIIT as a Staff Scientist, where she directed a multi-disciplinary research program and mentored postdoctoral scholars, graduate students, and undergraduates (Director of Education, 2001–2004), prior to becoming the Director of Investigative Toxicology at Integrated Laboratory Systems, a federal and commercial CRO. Her experience covers both research and regulatory-driven studies for conducting risk and safety assessments for industrial chemicals, agrochemicals, biopharmaceutical and pharmaceutical agents, and food and consumer products. She has published in the peer-reviewed toxicology literature, and has also managed testing programs for regulatory submission. Dr. Borghoff has served as an Associate Editor for Toxicological Sciences (2004–2008) and on the editorial boards of Toxicological Sciences, Chemical-Biological Interactions, Toxicology Letters, and currently, the International Journal of Toxicology. She has participated in a number of working groups and panels for international organizations, including the International Programme on Chemical Safety, European Centre for Ecotoxicology and Toxicology of Chemicals, International Agency for Cancer Research, and the Voluntary Children’s Chemical Evaluation Program. Dr. Borghoff has served as a reviewer for individual and program grants for NCI, NIEHS, and the US EPA (e.g., Superfund, Engineered Nanoparticles, Chemical Disposition). She is currently a member of the American College of Toxicology and the Society of Environmental Toxicology and Chemistry, and is a diplomate of the American Board of Toxicology.

Goals for SOT: It is an honor to be considered as a candidate for the position of Vice President-Elect within SOT. My goals for our Society will focus on engaging members in three broad areas reflected in our strategic priorities: 1) expand educational opportunities at all levels; 2) increase our visibility and cross-disciplinary collaboration with the broader scientific community, and 3) ensure the health and financial stability of the Society.

The strength of SOT is the diversity of our membership, not only in terms of gender and race/ethnicity, but expertise across numerous scientific disciplines and employment sectors worldwide. This diversity of perspectives will help us meet the challenge of achieving our mission: “To create a safer and healthier world by advancing the science and increasing the impact of toxicology.” We must work together with our Component Groups (Special Interest Groups, Specialty Sections, and Regional Chapters) to create and foster broad collaboration through innovative programs that promote the recruitment and training of students, postdoctoral scholars, and scientists of diverse disciplines to the field of toxicology.

Providing educational and training opportunities to our members is the cornerstone to maintaining a vibrant scientific society. This is especially important during this time of evolving tools and technologies used in both basic research and within the changing paradigm of safety testing and risk assessment. Advances in technology have also provided a mechanism that allows participation in educational opportunities through webinars and online continuing education classes, enhancing our ability to reach our global scientific community throughout the year. We must continue support of our Component Groups and other committees to develop content for these educational forums.

Creating a mechanism to fully support these educational efforts will engender recognition of the diverse expertise of our membership and will strengthen the credibility of toxicology among the broader scientific community. Such recognition will cultivate cross-disciplinary research efforts, assist in identifying funding sources, and provide opportunities for recruitment of scholars from different scientific fields.

To maintain SOT’s position as the premier professional society in toxicology, we must maintain our Society’s strong financial foundation. To that end, I will fully support continued efforts to ensure our scientific journal and Annual Meeting are current and relevant to our membership, while engaging members to identify opportunities to broaden the depth and outreach of both these vital activities.

Serving the Society is a privilege, and if elected, I will work tirelessly to advance our vision, values, and strategic priorities.

Treasurer-Elect (Vote for one of two)

4

Craig Rowlands PhD, DABT

Employer Underwriters Laboratories (UL), Supply Chain & Sustainability


Education Texas A&M College of Veterinary Medicine & Biomedical Sciences, PhD, Toxicology, 1993; Texas A&M University, BS, Biochemistry, 1987.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: CCT Organizing Committee for FutureTox Co-Chair 2011–2013; CCT Organizing Committee for Toxicoepigenetics 2015–2017; Contemporary Concepts in Toxicology Conferences Committee 2015–present, Co-Chair 2016–2017, Chair 2017–present; Continuing Education Committee 2010–2013, Co-Chair 2011–2012, Chair 2012–2013; Specialty Section Collaboration and Communication Group 2014–2016; Michigan Regional Chapter 2013–2015; Mechanisms Specialty Section 2005–2010; Molecular and Systems Biology Specialty Section 2009–present, Junior Councilor 2010–2011, Senior Councilor 2011–2012, Vice President-Elect 2012–2013, Vice President 2013–2014, President 2014–2015, Past President 2015–2016; Risk Assessment Specialty Section 2010–2012; Carl C. Smith Student Mechanisms Award 1993.

Experience: Dr. Craig Rowlands is Senior Scientist at Underwriters Laboratories (UL), Supply Chain & Sustainability. Prior to joining UL, he was a Senior Scientist and Research Leader at The Dow Chemical Company Department of Toxicology, Environmental Research and Consulting having served in several roles as a leader of an environmental toxicant research program, leader of the bioprofiling group of Dow’s Predictive Safety Center and supporting several Dow businesses as a corporate toxicologist. Before joining Dow, Dr. Rowlands was a Staff Fellow at the US Food and Drug Administration, Center for Food Safety and Applied Nutrition where he served as a scientific reviewer for food ingredient health claims. Throughout his career he has focused on the translation from in vitro and animal studies to assessment of human safety/efficacy employing multiple modalities including molecular-, cellular- and systems-biology technologies. Among his current activities he serves on the US EPA Science Advisory Committee for Chemicals and is an external advisor on an EPA STAR Grant and a NIEHS Training Grant.

Goals for SOT: Paramount to this role is the continued financial security of SOT that will include identifying opportunities for expanding financial support. Thus, my goals will be to maintain the financial health of the SOT, through close consultation with Council and ensuring a sound annual budget that includes close management of the Society’s accounts and financial matters. Other goals are to continue the progress made by the current treasurer and the Council in developing new opportunities for funding mechanisms for investigators and SOT activities through furthering philanthropic corporate resources.

Treasurer-Elect (Vote for one of two)

5

Anthony M. Ndifor PhD

Employer Janssen Research & Development LLC


Education University of Liverpool, UK, PhD, Pharmacology 1992; University of Liverpool/Liverpool School of Tropical Medicine, MSc, Parasitology and Medical Entomology 1988; University of Liverpool, BSc, Pharmacology 1987.

SOT-Elected Positions: Nominating Committee 2013–2015.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Committee on Diversity Initiatives 2006–2009; Continuing Education Committee 2016–present; Education Committee Ad Hoc Member 2013–present, Ad Hoc GSSEP 2017; Finance Committee 2012–2015; Global Strategy Task Force 2009–2012; Southern California Regional Chapter 2002–present, Councilor 2003–2005, Secretary 2005–2009, Vice President-Elect 2009–2010, Vice President 2010–2011, President 2011–2012, Past President 2012–2013; Toxicologists of African Origin Special Interest Group 2008–present, Organizing Committee 2007–2008, Secretary/Treasurer 2008–2010 and 2014–2015, Councilor 2012–2014; Drug Discovery Toxicology Specialty Section 2009–present; Immunotoxicology Specialty Section 1999–2008; Regulatory and Safety Evaluation Specialty Section 2008–present.

Experience: Dr. Ndifor is a Director in the Preclinical Development and Safety Department at Janssen Research & Development LLC, part of the Johnson & Johnson family of companies. He has previously held positions at Parke-Davis in Michigan and Amgen in California. Dr. Ndifor has more than 18 years of experience providing preclinical safety assessment expertise and leadership within drug development teams. He has broad expertise in both biologics and small molecule development across various therapeutic areas including Oncology, Neuroscience, Immunology, Metabolic Diseases, and Infectious Diseases. Dr. Ndifor is a Board member and Treasurer/Secretary of Toxicology Education Foundation, which is dedicated to increasing public understanding of toxicology through access to objective easy to understand information on common toxicants. He has served as a ToxScholar and frequently visits grade schools and attends career fairs to introduce toxicology to students. He is very proud to have served as a member of the SOT Global Strategy Task Force which led to the establishment of the Global Senior Scholar Exchange Program to strengthen toxicology training and expertise in developing countries. He continues to be engaged in this program as Ad hoc Member of the Education Committee. He is passionate about improving diversity in the pharmaceutical industry through mentoring and facilitating access for under-represented groups.

Goals for SOT: I am deeply honored to be nominated as candidate for this position. Having served on the Society’s Finance Committee for several years, I bring a good understanding of the financial landscape of our Society. Thanks to the foresight and sound investment practices of previous councils, our Society can boast of a healthy fiscal base. As Treasurer and part of your Council, my goal will be to ensure we remain on AAA fiscal footing, ensure financial responsibility and integrity while investing in our membership, and our future globally. Our strong structural and fiscal foundation should allow us to be innovative in meeting our guiding principles of “Serving the needs of our discipline and our members to enhance human, animal, and environmental health; providing opportunities for life-long learning and intellectual scientific stimulation; and Ensuring diversity of representation in all activities of the Society.” We continue to make great strides in meeting these core principles, in delivering outstanding CE courses and meeting sessions, in grooming young toxicologists and making our Society notable in the scientific community. But we must challenge ourselves to be bolder, to feel slight discomfort, to study the competition so we can remain relevant not only to the established members, currently leading the affairs of the Society or heading college departments, but also to the next generation in college, graduate school, and indeed in K–12. The global need for toxicologists provides an opportunity for growth within the Society. How we position ourselves to serve these global communities may determine our future success as stewards of human and environmental safety.

Councilors (Vote for no more than two of four)

6

Courtney E. W. Sulentic PhD

Employer Wright State University


Education Michigan State University, PhD, Pharmacology and Toxicology, 1999; Lake Superior State University, BS, Biology, 1992.

SOT-Elected Positions: Awards Committee 2016–2018, Co-Chair 2016–2017, Chair 2017–2018.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Career Resource and Development Committee 2010–2013, Co-Chair 2011–2012, Chair 2012–2013; Continuing Education Committee 2007–2010; Undergraduate Strategy Work Group/Task Force 2014–2017; Education Summit Organizing Team 2010–2012; Mentoring Breakfast Planners 2012–2014; Regional Chapter Collaboration; Communication Committee 2011–2013; Women in Toxicology Mentoring Initiative 2011–2012; Ohio Valley Regional Chapter 2002–present, Secretary 2006–2009, Vice President 2009–2010, President-Elect 2010–2011, President 2011–2012, Past President 2012–2013; Women in Toxicology Special Interest Group 1995–present; Immunotoxicology Specialty Section 1996–present, Steering Committee for a Regional Immunotoxicology Meeting 2011–2012, Awards Committee 2007–2008; Molecular Biology Specialty Section 2006–present; Colgate-Palmolive Grant for Alternative Research 2006.

Experience: Dr. Sulentic is currently an Associate Professor within the Department of Pharmacology and Toxicology at Wright State University, Boonshoft School of Medicine. Prior to joining the faculty at Wright State in November 2003, she was a postdoctoral fellow in the laboratory of Dr. Norbert Kaminski at Michigan State University and was funded under an NIEHS National Research Service Award. Her research is currently funded by NIH. Along with past NIEHS funding she has received several intramural grants as well as the Colgate-Palmolive Grant for Alternative Research from SOT. Her overall research goal is to elucidate, at the cellular and molecular level, the human health implications of altered antibody expression by xenobiotics such as the environmental contaminant, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and the role of specific genetic factors in influencing individual susceptibility to xenobiotics. Dr. Sulentic has been very active in training undergraduate and graduate students and is involved in professional societies including the American Society for Pharmacology and Experimental Therapeutics, the American Association of Immunologist, and particularly SOT and the Ohio Valley Regional Chapter.

Goals for SOT: My service on several SOT committees and outreach efforts has given me an opportunity to be actively involved in defining and implementing objectives/tactics specific to the Strategic Priorities and Objectives for the Society. Because of these efforts, I have a broader perspective of the goals of several groups and have found significant points of overlap between the objectives and specific tasks of different committees and subcommittees. To avoid duplication of efforts, I have tried to bring a greater awareness of the efforts of other groups and to increase the communication between these groups. If elected to a Councilor position, my main objective would be to identify common goals/tactics between different committees and to facilitate increased communication and collaborative efforts between these committees. I believe the Society has developed a sound and achievable strategic plan with specific priorities and objectives that reflect the interests of our members. With my current and past experience on SOT committees and outreach activities, I will bring continuity and increased efficiency to implementing the Society’s strategic objectives.

Councilors candidates continued on next page 4


7

Vicente Santa Cruz PhD

Employer Chevron Phillips Chemical Company LP


Education University of Texas Medical Branch at Galveston, PhD, Biomedical Sciences, Experimental Pathology, 2001; NIEHS Toxicology Trainee, 2001; University of Texas at El Paso, BS, Clinical Laboratory Sciences with Honors, 1995.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Committee on Diversity Initiatives 2005–2008, Co-Chair 2005–2006, Chair 2006–2008; Education Committee 2013–2016, Co-Chair 2014–2015 Chair 2015–2016; Education Subcommittee: Graduate Education 2015–2016; Education Subcommittee: K–12 2015–2016; Education Subcommittee: K–12 Regional Chapter Contacts 2015–2016; Education Subcommittee: Undergraduate Education 2015–2016; Interplay of Undergraduate Programs Task Force Chair 2016–2017; Lone Star Regional Chapter 2009–present; Hispanic Organization of Toxicologists Special Interest Group 2007–present; Occupational and Public Health Specialty Section 2006–present; Regulatory and Safety Evaluation Specialty Section 2006–present.

Experience: Dr. Santa Cruz received his BS in clinical laboratory science from the University of Texas at El Paso in 1995. He received his PhD in toxicology-experimental pathology from the University of Texas Medical Branch at Galveston in 2001 under the mentorship of the late Dr. Mary F. Kanz. In 2001, Dr. Santa Cruz started his career as an industrial toxicologist at Chevron Phillips Chemical Company. He supported company-wide product stewardship efforts that included human health and environmental risk assessments. He actively participated and served as chairman in various industry wide consortia in the US and Europe. From 2007–2010, Dr. Santa Cruz served as Director of Regulatory Compliance in Brussels, Belgium. He focused on providing expert support in writing industry guidance documents for REACH compliance and was instrumental in establishing the regulatory office in Europe for Chevron Phillips. Since 2010, Dr. Santa Cruz has accepted multiple roles that have developed his business and management acumen. Dr. Santa Cruz served as specialty chemicals project director where he was responsible for existing product development projects and future capital investment projects. It was here that Dr. Santa Cruz gained business and engineering knowledge for product manufacturing scale up. Dr. Santa Cruz then accepted a commercial product management role to oversee profit and loss of the worldwide organosulfur portfolio of chemicals. After gaining valuable experience in various corporate business roles, he accepted the role of operations and utilities superintendent at the drilling specialties manufacturing site where he managed daily operations and process safety management. Recently, Dr. Santa Cruz’s returned to EHSS to manage the industrial hygiene program and medical clinic at the largest Chevron Phillips site. Over the last 10 years, Dr. Santa Cruz has gained invaluable experience in building business strategies and implementation plans. He was also a Diplomate of American Board of Toxicology 2005 and 2010.

Goals for SOT: I am honored to be considered for a Councilor position. My service to SOT has focused on the student pipeline leading to careers in toxicology. I have also focused on expanding our global networks to countries such as Nigeria, Nepal, Thailand, and Colombia. I have witnessed the shared science of toxicology broaden our networks and add several more layers to the core of our Society. We are connected to international regulations, public thirst for answers, corporate innovations, biotechnology, and academic research education, to name a few. We continue to grow and a degree of complexity is inevitable as we ensure that we meet all of our membership’s needs.

My goal for the Society is to look clearly at our vision and assess what our membership sees. We will need to encourage new ideas and also review past experience from our long-time members. Is our Society moving in the direction that they once envisioned? Does complexity affect quality and reduce opportunities? Do we challenge complexity and make it simple? Where do we invest based on the Society’s climate needs? Are we looking far enough into the future to ensure sustainability?

My goal is to also use my business experience to bring the right balance in overall decision making. I plan to support and guide committees to success by understanding their interests and representing them during council meetings. If I cannot represent them, I will invite them to deliver their message. I also plan to be transparent and guide them based on the vision that Council establishes for near and long term goals. I am prepared to accept the challenges and ensure that we continue to move SOT to continued success.


8

Barbara L. F. Kaplan PhD

Employer Mississippi State University


Education Michigan State University, PhD, Pharmacology and Toxicology, 2001; University of California Davis, BS, Environmental Toxicology, 1992.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Career Resource and Development Committee 2010–2013; Education Committee 2014–2017, Co-Chair 2015–2016, Chair 2016–2017; Education Subcommittee: Graduate Education Co-Chair 2014–2016; Mentoring Breakfast Planners 2013–2014; Women in Toxicology Mentoring Initiative 2012–2013; Undergraduate Consortium Task Force Chair 2017–present; South Central Regional Chapter 2013–present; Immunotoxicology Specialty Section 1997–present.

Experience: Dr. Kaplan earned her PhD in Pharmacology and Toxicology from Michigan State University. She conducted postdoctoral research in tumor immunology at the University of Chicago, then returned to Michigan State University as a Research Assistant Professor. She is now an Assistant Professor in the Center for Environmental Health Sciences at Mississippi State University College of Veterinary Medicine (MSU-CVM).

In addition to Dr. Kaplan’s experience with the Society noted above, Dr. Kaplan teaches immunology to veterinary students and pharmacology and toxicology to undergraduate and graduate students at MSU. Dr. Kaplan has been active in mentoring DVM-PhD students, undergraduate students, and veterinary students participating the Summer Research Experience at MSU-CVM. Dr. Kaplan also mentored an undergraduate student from Mississippi University for Women for a summer, which led to a ToxScholar visit. During Dr. Kaplan’s ToxScholar visit to the Mississippi University for Women, Dr. Kaplan met with about 30 undergraduate students and introduced toxicology principles, toxicology careers, and opportunities available from SOT.

Dr. Kaplan has contributed to the last three editions of Casarett and Doull’s Toxicology (chapter on Immunotoxicology), and this past summer was one of 32 accepted attendees to the Alan Alda Center for Communicating Science Boot Camp in Stony Brook, New York.

Goals for SOT: I am honored and humbled to be considered for one of the Councilor positions for the Society.

One of my goals as Councilor will be to support the continued efforts of the Society for recruitment and retention of students to toxicology. Introducing students to toxicology is critical for the future of our science and the Society. During the last few years on the Education Committee and the Undergraduate Consortium Task Force, I have become familiar with the SOT’s focus of introducing toxicology at the level of undergraduate students. I will continue to support our strong programs in undergraduate internships, travel awards, undergraduate programming at the Annual Meeting, and ToxScholar visits.

My second goal as Councilor is to be a tireless advocate for science and toxicology. I will continue to learn from, and teach, fellow members about the importance of promoting their science to peer scientists and the public.

My third goal as Councilor will be promotion of the importance of mentoring in science. All of us have experience with the advisor-graduate student mentoring relationship, but mentoring is critically important at all stages of one’s career. Constructive feedback and continued learning from mentors is one way to continue our education in the years beyond the classroom.

Councilors candidates continued on next page 4


9

Matthew J. Campen PhD, MSPH

Employer University of New Mexico


Education University of North Carolina at Chapel Hill, School of Public Health, PhD, MSPH Environmental Health, 2000, 1997; Virginia Polytechnic Institute and State University, BS, Biochemistry, 1994.

SOT-Elected Positions: Awards Committee 2015–2017.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Board of Publications 2012–2016, Co-Chair 2013–2015, Chair 2015–2016; Disease Prevention Task Force 2008–2011, 2012–2013; Research Funding Committee 2008–2009; ToxSci Associate Editor 2012–present, Interim Co-Editor-in-Chief, 2013; Mountain West Regional Chapter 2002–present, Vice President 2005–2006, President 2006–2007, Past President 2007–2008; Cardiovascular Toxicology Specialty Section 2009–present, President-Elect 2009–2010, Vice President 2010–2011, President 2011–2012, Past President/Councilor 2012–2013; Clinical and Translational Toxicology Specialty Section 2013–present; Inhalation and Respiratory Specialty Section 2006–present, Vice President-Elect 2017–present; Occupational and Public Health Specialty Section 2012–present; Achievement Award 2014; Inhalation and Respiratory Specialty Section Young Investigator Award 2013.

Experience: Matthew Campen, is a Regents’ Professor in the Department of Pharmaceutical Sciences, University of New Mexico, where he has been since 2009. His laboratory is broadly interested in the cross-talk of the cardiovascular and respiratory system in health and disease. His primary research focus involves the impact of inhaled toxicants, especially common air pollutants, on vascular function and injury. Dr. Campen was trained in Environmental Health at the University of North Carolina School of Public Health where he earned a Master’s in Public Health and a PhD in Environmental Health, followed by a postdoctoral fellowship in the Johns Hopkins University School of Medicine. Prior to his current appointment, he worked as an independent scientist at the Lovelace Respiratory Research Institute in Albuquerque, conducting both grant- and contract-funded research. Dr. Campen has published more than 80 peer-reviewed articles. Dr. Campen currently serves as an Associate Editor for Toxicological Sciences and in 2013, he shared the Toxicological Sciences Editor-in-Chief position with Dr. John Lipscomb. He is also on Editorial Boards for Environmental Health Perspectives, Inhalation Toxicology, and Toxicology Letters. He has been awarded the SOT Achievement Award and the Inhalation and Respiratory Specialty Section Young Investigator Award. His contributions to the Society include helping to establish the Cardiovascular Specialty Section, executive duties for the Mountain West Regional Chapter, and work on several other committees, including the Publications Committee and Disease Prevention Task Force. He is currently Vice President-Elect for the Inhalation and Respiratory Specialty Section.

Goals for SOT: The Society of Toxicology has been a major factor in my career and my overarching goal is to ensure that the Society continues to benefit students and young investigators. To accomplish this, the Society needs to continue to be an outstanding resource for training, recruitment, and networking. I hope to improve communication between academic programs and industry and government employers, to make sure that students in the field of toxicology are well trained and have the best chance to make positive impacts in their careers. As a Councilor, I will actively look to represent the balanced perspectives and interests of the SOT membership.

Awards Committee (Vote for no more than three of six)

10

Yvonne Will PhD

Employer Pfizer Inc.


Education Oregon State University, PhD, Biochemistry and Biophysics, 1999.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Contemporary Concepts in Toxicology Conferences Committee 2017–present; Organizing Committee for The Use of Cardiomyocytes for the Assessment of Proarrhythmic Risk Chair 2015–2017; Northeast Regional Chapter 2007–present; Southern California Regional Chapter 2002–present; Drug Discovery Toxicology Specialty Section 1996–present, Vice President-Elect 2011–2012, Vice President 2012–2013, President 2013–2014, Past President 2014–2015; In Vitro and Alternative Methods Specialty Section 2009–present; Mechanisms Specialty Section 1996–present.

Experience: Dr. Yvonne Will pursued her graduate studies at Oregon State University in the lab of Dr. Donald Reed where she focused on the relationships between glutathione deficiency and cellular and mitochondrial function/dysfunction. During her years at MitoKor, San Diego (2000–2003) she was involved in drug discovery aimed on improving mitochondrial function or preventing mitochondrial dysfunction in obesity, diabetes, and CNS related diseases.

Dr. Yvonne Will joined Pfizer in 2003 as a group leader in Drug Safety at Pfizer La Jolla, pioneering a screening paradigm for drug induced mitochondrial toxicity, supporting many therapeutic areas. This platform has been adapted throughout all major pharmaceutical companies. During that time, she also held an adjunct faculty position at San Diego State University in the Toxicology program where she conducted lectures, taught laboratory courses, and mentored MS students. In the fall of 2007, Dr. Will transferred to Pfizer Groton to lead a group of scientists in the Compound Safety Prediction Group within Medicinal Chemistry. This group was set out to conduct in vitro safety assessment as early as possible within the drug discovery process to reduce late stage attrition. Dr. Will’s group has pioneered many new technologies throughout the years. Dr. Will has given many national and international lectures, conducted workshops and seminars, and continues to publish numerous papers each year in peer-reviewed journals, including a book on Drug Induced Mitochondrial Toxicity in 2008 and a book on Drug Discovery Toxicology in 2016. In 2012, Dr. Will was honored with the Connecticut Technology Council’s Woman Research Innovation and Leadership Award. Dr. Will’s passion is to develop young scientists through external influence such as publications and participations in national meetings. In September of 2014, Dr. Will became the Head of Science and Technology for Drug Safety within Pfizer. As such she works on strategy as well as innovation and developing the next generation of scientists through a postdoctoral program as well as mentoring efforts. In 2015, Dr. Will became a Fellow of the Academy of Toxicological Sciences. In September of 2016, in addition to her role as the Science and Technology Strategy Lead, she also was appointed to lead the Drug Discovery Toxicology Efforts for Drug Safety, Pfizer. Dr. Will’s passion is to develop young scientists through external influence such as publications and participations in national meetings.

Goals for SOT: During the many years of my active membership, I have developed and chaired many CE courses, symposia, and workshops. My research group has contributed with hundreds of poster presentations. I have served as the President of the Drug Discovery Toxicology Specialty Section. My goal is to continue to serve the Society where my skill sets and experience will provide the most valuable contribution.


11Awards Committee candidates continued on next page 4

Robert A. Roth PhD, DABT

Employer Michigan State University


Education Yale University, Postdoctoral Fellow, 1975–1977; The Johns Hopkins University, PhD, Biochemical Toxicology, 1975; Duke University, BA, Chemistry, 1968.

SOT-Elected Positions: Awards Committee 2007–2009, Chair 2008–2009; Councilor 1993–1995; Membership Committee Council Contact 1993–1994.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Animals in Research Committee 1984–1986; Board of Publications 1998–2003, Ad Hoc Member 1998–1999, Chair 1999–2001; Education Committee 1990–1995, Council Contact 1994–1995; Endowment Fund Board 2016–present, Co-Chair 2017–present; Program Committee 1988–1990; Research Funding Committee 2011–2014; Central States Regional Chapter 2014–2016; Michigan Regional Chapter 2006–present; Midwest Regional Chapter 2012–present; Comparative and Veterinary Specialty Section 2014–present; Food Safety Specialty Section 1984–present, Vice President-Elect 1999–2000; Vice President 2000–2001, President 2001–2002, Past President 2002–2003; Drug Discovery Toxicology Specialty Section 1984–present; Immunotoxicology Specialty Section 1984–present; In Vitro and Alternative Methods Specialty Section 1984–present; Mechanisms Specialty Section 1984–present, Nominating Committee 1983–1984, Councilor 1986–1988, Vice President-Elect 1988–1989, Vice President 1989–1990, President 1990–1991, Past President 1991–1992; Toxicologic and Exploratory Pathology Specialty Section 2014–present; AstraZeneca Traveling Lectureship Award 2006; Midwest Regional Chapter Kenneth P. DuBois Award 2001.

Experience: Dr. Roth is Professor of Pharmacology and Toxicology at Michigan State University and a Diplomate of the American Board of Toxicology and has served on its Board of Directors. He has served on several NIH review groups, most recently the XNDA Study Section. He has trained numerous graduate students and postdoctoral fellows and directed the toxicology graduate program at Michigan State University for 13 years. Dr. Roth has published more than 250 peer-reviewed research articles and reviews in the areas of pulmonary and hepatic toxicology and has received the MERIT Award from the NIEHS. He has been active in the SOT for many years and received the Burroughs Wellcome Toxicology Scholar Award. His major current research interest focuses on inflammatory stress as a determinant of susceptibility to drug-induced liver injury.

Goals for SOT: The contributions of SOT members in research and training ranges from enhancing the understanding of toxicologic mechanisms to improving risk assessment and regulation of environmental chemicals and drugs. The Society must maintain a balance between these various activities in its programs. Recipients of major SOT awards should reflect this balance as well as being outstanding contributors to the discipline of toxicology and to the Society. If elected to the Awards Committee, I will work toward identifying and selecting the most appropriate candidates for the prestigious SOT awards.


12

Kenneth E. McMartin PhD

Employer Louisiana State University Health Sciences Center


Education University of Iowa, PhD, Pharmacology, 1977; Coe College, BA, Chemistry, 1973.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Clinician-Scientist Engagement Task Force 2015–present, Co-Chair 2016–2017, Chair 2017–present; Committee on K–12 Education Chair 2005–2006; IUTOX Councilors 2013–2016; K–12 Subcommittee 2003–2006; Regional Chapter Meeting Organizing Committee 2003 and 2009; Scientific Liaison Coalition—Governance Committee 2010–present, American Academy of Clinical Toxicology (AACT) 2013–present; SOT Liaison Coalition Representatives (IUTOX) Councilor 2013–2016; Scientific Program Committee 2008–2012; Specialty Section Collaboration and Communication Group Co-Chair 2013–2014, Chair 2014–2015; South Central Regional Chapter 2002–present, Judge, Graduate Student Awards, 2000, 2003, 2005, and 2008, Vice President-Elect 2002–2003, Vice President, 2003–2004, President, 2004–2005, Past President, 2005–2006; Mechanisms Specialty Section 1984–present, Judge, Carl Smith Graduate Student Awards, 1989 and 2009; Clinical and Translational Toxicology Specialty Section 2011–present, Interim Vice President 2011–2013, Vice President 2013–2014, President 2014–2015, Past President and Councilor 2015–2016; Mechanisms Specialty Section 1984–present; Translational Impact Award 2010.

Experience: Dr. McMartin was a Postdoctoral Fellow at the Karolinska Institute in Stockholm, Sweden from 1977–1979 and has been a faculty member (now Professor) in the Department of Pharmacology, Toxicology and Neuroscience at LSU Health Sciences Center, Shreveport since 1980. His research focus has been on the mechanisms of renal toxicity of glycols and on the development of mechanism-based antidotes for clinical poisonings. He has received the following awards including the Kenneth Morgareidge Award in Toxicology from ILSI in 1988, Fellow in the American Academy Clinical Toxicology in 2009, the Society of Toxicology Translational Impact Award in 2010. He is serving on the Board of Scientific Counselors of the National Toxicology Program and is the current Chair of this board. He also is on the Senior Editorial Board for the journal Clinical Toxicology. Dr. McMartin has participated as a member of numerous special emphasis panels and study sections for NIH, as well as review panels for NTP-CERHR, WHO (IPCS), US EPA, ATSDR and NTP-ROC Expert Panels.

Goals for SOT: The Awards Committee plays a critical role in helping SOT reach strategic goals. Giving awards to members is one of the major goals of any society and SOT has done an excellent job of providing this service to its members. Service on the Awards Committee will be an honor itself, since the committee is primarily responsible for choosing SOT award winners. Awards are important for recognizing members for their achievements, because they provide value to the hard work that brings about these achievements. Awards to senior members honor their lifetime accomplishments and as such reflect a validation of excellent science, while awards to young toxicologists can help to advance their careers and status within their place of employment. The variety of awards offered by SOT serve an additional purpose—they help to maintain member’s interest in SOT and its programs. This interest can in turn lead to greater involvement of members in SOT programs and committees, which helps to maintain an active society.



J. Eric McDuffie BS, MBA, PhD

Employer Janssen Research & Development LLC


Education The University of Michigan Medical School, Pathology Postdoctoral Research Fellowship, 1998–2000; Meharry Medical College, PhD, Pharmacology, 1998; Benedict College, BS, Biology, 1994.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: CCT Organizing Committee for miRNA Biomarkers for Toxicology 2015–2016; Southern California Regional Chapter 2009–present, Vice President-Elect 2017–present; Toxicologists of African Origin Special Interest Group 2009–present; Clinical and Translational Toxicology Specialty Section 2014–present; Drug Discovery Toxicology Specialty Section 2012–present; Immunotoxicology Specialty Section 2015–present; In Vitro and Alternative Methods Specialty Section 2014–present; Mechanisms Specialty Section 2012–present; Molecular and Systems Biology Specialty Section 2014–present; Neurotoxicology Specialty Section 2015–present; Regulatory and Safety Evaluation Specialty Section 2015–present; Risk Assessment Specialty Section 2014–present; Stem Cells Specialty Section 2015–present; Toxicologic and Exploratory Pathology Specialty Section 2009–2013.

Experience: J. Eric McDuffie is a candidate for the SOT’s Awards Committee. The experience that he brings to the position stems in part from his previous role as a member of the Johnson & Johnson Research & Development Awards Committee which determines the final nominees for the highest honors bestowed upon the company’s scientists. Dr. McDuffie has more than 17 years of experience as preclinical toxicologist in the pharmaceutical industry. In his current career, he is heading the Mechanistic & Investigative Toxicology team at the Johnson & Johnson/Janssen Pharmaceutical Research & Development site located in La Jolla, California, USA, where the research focus includes the development of drug candidates for immunologic and neurologic disease indications. He has co-authored more than 30 peer-reviewed manuscripts and delivered numerous platform presentations. Dr. McDuffie Co-Chaired the 2012 SOT Workshop, “Non-Rodents can be monitored, too…characterization of novel biomarkers of drug-induced kidney injury (DIKI) in rats, canines, non-human primates and humans.” He served as Co-Editor for the benchmark book, Drug Discovery Toxicology: From Target Assessment to Translational Biomarkers (2016). Dr. McDuffie serves as Co-Chair for the Nephrotoxicity Working Group within the Critical Path Institute’s Predictive Safety Testing Consortium which qualifies translatable kidney safety biomarkers. He is a Mentor in the 2017–2018 ToxMSDT Program, which is funded by the NIH in order to foster undergraduates’ interest in Careers in Toxicology.

Goals for SOT: If elected by a plurality vote of ballots cast, as a member of the SOT’s Awards Committee, I would gain personal satisfaction through efforts intended to highlight SOT members who actualize “outreach and education” objectives to “Guide to Careers in Toxicology.” My benchmarks would include but not be limited to the individual’s support to existing initiatives such as the “SOT Online Mentoring Program.” Additionally, my scope would include awarding individuals who have demonstrated strong commitment to advancing the mission of 3R’s (replacement, reduction, and refinement) for animal use in toxicology research. I would also seek to recognize toxicologists who strategically influence regulatory authorities in their strategic quest to systematically adopt next-generation in vitro (2D, 3D and microphysiological systems) and in silico platforms that were envisaged to support drug discovery/screening during the lead optimization stage, early disease diagnosis, and/or prevention in humans or companion animals. Lastly, I would aim to illuminate researchers who consistently foster communications between SOT members across the globe, specifically with intent to create a more sustainable earth through nearly inestimable application of toxicology.


14

Susan C. Hester PhD

Employer US Environmental Protection Agency


Education University of North Carolina, PhD, Pathology and Laboratory Medicine, 2003; University of North Carolina, MS, Biology, 1995; University of North Carolina, BS, Medical Technology, 1972.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Risk Assessment Specialty Section 2014–present.

Experience: Dr. Hester joined the US EPA in 1997 and her career initially began in National Environmental Effects Research Laboratory in the Environmental Carcinogenesis Division but later transitioned into The Integrated Systems Toxicology Division. During her career she has developed a rich skill set using molecular approaches including transcriptional analysis to investigate effects of environmental chemicals on human health. She has received more than 15 Scientific Technical Awards, published more than 130 peer-reviewed papers and abstracts, presented several SOT Continuing Education sessions and talks, presented numerous invited seminars during the past 20 years in the US and abroad. Her current research efforts address exceptionally difficult research problems and her national/international leadership has been recognized within and outside of the Agency. She has served as an Adjunct Professor at the University of North Carolina, Chapel Hill in the Department of Pathology and Laboratory Medicine. During her career she has mentored more than 30 postdoctoral trainees, with research focus on investigating mechanisms involved in toxicology and cancer disciplines.

Dr. Hester has been involved in vigorous and extremely collaborative research effort within Chemical Safety for Sustainability (CSS) particularly related to the development of toxicogenomics as a research tool to inform chemical mode of action and tumorigenic potency. Dr. Hester’s primary research area has been on multigene analytics to characterize quantitative relationships between pathways and disease with the ultimate goal of developing predictive models of toxicity. Presently, she is involved with tasks in the US EPA’s Chemical Safety for Sustainability Research Plan. Her current work in this task is organized into three major themes: 1) tools to facilitate AOP discovery and development, 2) short-term predictive models to identify risk (or the lack of risk), and 3) epigenetic biomarkers of susceptibility. The impacts of this research are to better integrate apical and genomic data streams; support chemical screening and prioritization efforts; inform decisions regarding biological significance or adversity based on genomic data; identify novel biomarkers for effect and exposure; inform safety evaluation for chemicals with potential for early life exposure; and support assessment of human health relevance through comparative analysis of molecular responses and pathways across species.

Goals for SOT: If elected, my goals for the SOT Awards Committee would reinforce the long-standing SOT tradition of rewarding excellence in the sciences for both young scientists and well-accomplished senior scientists. This has been and will continue to be a key activity for the Society’s diverse membership. Historically, the core mission of the Society has been producing and communicating sound science to improve all sectors of public health. I would work to recognize and reward deserving individuals for their outstanding achievements and service to the Society.



Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Celebrating Membership Accomplishments Task Force 2012–2014.

Experience: Dr. Nancy Claude, PhD, doctor in pharmacy from the Faculty of Paris, has more than 25 years of experience in the pharmaceutical industry. She is currently director of Non Clinical Drug Safety at SERVIER Group (Suresnes, France). With a team of 100 people, she is leading efforts in investigative and regulatory toxicology. Dr. Claude has been an active member of the SOT since 2000. She also served on the French Society of Toxicology (Honorary President), EUROTOX (2010–2012 President and now Honorary Member) and organized EUROTOX in Paris, 2011. She is a member of the French Academy of Pharmacy. Dr. Claude also has some teaching responsibilities and more than 70 publications and communications. She also received the National Order of Merit (France).

Goals for SOT: During the 17 last years, I have seen the SOT dramatically grow with a strong and focused effort towards internationalization of the Society. As a member of the Awards Committee, I would participate actively to the globalization of SOT with the recognition of scientists from various part of the world who’s achievements in toxicology meet our ambition of a healthier world.

Nancy D. Claude PhD

Employer SERVIER Group


Education Faculty of Pharmacy, Paris V, PhD, Toxicology, 1992; Faculty of Pharmacy, Paris V, MS, Toxicology, 1989; Faculty of Pharmacy, Paris XI, PharmD, Toxicology, 1982.

Membership Committee (Vote for no more than three of six)

16

Sharmilee P. Sawant PhD, DABT, RAC

Employer Halyard Health Inc.


Education University of Louisiana at Monroe, PhD, Toxicology, 2005; University of Mumbai, India, MS, Pharmacology, 2000; University of Pune, Bachelor of Pharmacy, 1998.


Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Graduate Student Leadership Committee Executive Board 2004–2005; Scientific Liaison Coalition 2015–present; SIG Collaboration Group 2015–present; Specialty Section Postdoctoral Representative Committee 2006–2007; Student Advisory Council: Specialty Section Graduate Committee 2005–2006; Mid-Atlantic Regional Chapter 2005–2007; South Central Regional Chapter Student Representative 2004–2005; Southeastern Regional Chapter 2007–present; Association of Scientists of Indian Origin Special Interest Group 2006–present, Vice President-Elect 2017–present; Women in Toxicology Special Interest Group 2001–present, Student Representative 2005–2007, Councilor 2011–2013, Vice President 2014–2015, President-Elect 2015–2016, President 2016–2017, Past President 2017–present; In Vitro and Alternative Methods Specialty Section 2006–2009; Medical Device and Combination Product Specialty Section 2009–present; Risk Assessment Specialty Section 2007–present.

Experience: Dr. Sawant is currently an Associate Director of Global Product Safety for Halyard Health Inc., Alpharetta, GA. Halyard Health Inc., was formerly the Kimberly-Clark Corporation health care products business (until November 1, 2014). As a team leader (2011–present) and as a regulatory toxicologist (2007–2011) at Halyard Health and Kimberly-Clark, Dr. Sawant is responsible for the design, implementation, and interpretation of in vitro assays and in vivo GLP toxicology/biocompatibility studies for medical device development, and conduct of safety assessments for global regulatory submissions. Dr. Sawant was previously employed at Johnson & Johnson PRD, Raritan, NJ as a postdoctoral scientist in Mechanistic Toxicology (2005–2007). Dr. Sawant earned her PhD in Toxicology (2005) from University of Louisiana at Monroe, LA. She is a Diplomate of the American Board of Toxicology (2010) and holds a Regulatory Affairs Certification (RAC-US, 2017). Dr. Sawant obtained her Masters of Pharmaceutical Sciences in Pharmacology (2000) from University of Mumbai, India and Bachelors in Pharmacy from Pune University, India (1998). An active participant in the Society of Toxicology since 2002, Dr. Sawant has volunteered on several SOT committees and initiatives and served on several elected and appointed committees. Dr. Sawant’s engagement in SOT helped her gain scientific knowledge, develop leadership skills, and create an excellent network with fellow toxicologists. Dr. Sawant approaches her officer and leadership roles with tremendous energy and success. Dr. Sawant served on the SOT Nominating Committee (2015–2017) and promoted diversity within SOT by identifying qualified toxicologists with diverse backgrounds. Dr. Sawant has served on several positions in SOT Special Interest Groups (SIG) and Regional Chapters. She is currently the Vice President-Elect of the SOT’s Association of Scientist of Indian Origin (ASIO) SIG. In her various roles as Student Representative, Postdoctoral Representative, Councilor, and Vice President to Past President for the Women in Toxicology (WIT) SIG, Dr. Sawant strived to increase the involvement and recognition of women toxicologists within the Society. She has been actively involved with WIT SOT Awards Nomination Committee since 2014 facilitating the nomination of multiple female toxicologists for SOT national awards and three of the nominees were recipients of SOT awards in 2017.

Goals for SOT: As a member of the SOT Membership Committee, one of my goals will be to promote diversity as well as the global impact of the SOT. I will strive to specifically encourage membership and early engagement in SOT initiatives of undergraduate and graduate students, postdoctoral scholars, and junior scientists—these individuals are important for the Society’s future. I plan to work on expanding our membership with toxicologists with unique perspectives who bring to the field varied approaches from different sectors because of their gender, geographical location, ethnicity, employer type (industry, government, and academia), and career stages.


17Membership Committee candidates continued on next page 4

Terrence J. Monks PhD

Employer Wayne State University


Education University of London, St. Mary’s Hospital Medical School, PhD, Biochemical Pharmacology, 1978; Hatfield Polytechnic, BSc, 1st Class Honors, Applied Biology, 1975.


Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Scientific Program Committee 2008–2012; Scientific Program Committee Sponsored Sessions Policy Task Force Chair 2008; Gulf Coast Regional Chapter 1987–2012, Secretary 1992–1993, Vice President-Elect 1993–1994, Vice President 1994–1995, President 1995–1996, Past President 1996–1997; Michigan Regional Chapter 2015–present; Mountain West Regional Chapter 2012–2015; Carcinogenesis Specialty Section 1996–1998; Mechanisms Specialty Section 1987–present, Vice President-Elect 2000–2001, Vice President 2001–2002, President 2002–2003, Past President 2003–2004; AstraZeneca Traveling Lectureship Award 1993.

Experience: Dr. Monks currently serves as Assistant Vice President for Integrative Biosciences, and Professor of Pharmaceutical Sciences at Wayne State University. Dr. Monks previously served as Head of the Department of Pharmacology and Toxicology and Associate Dean for Research and Graduate Affairs at the University of Arizona College of Pharmacy. His first academic position was at the University of Texas at Austin, where he rose through the ranks to Full Professor and was the Founding Director of the Center for Molecular and Cellular Toxicology. Dr. Monks served as Chair of the Gordon Research Conference on Drug Metabolism, Chair of the International Advisory Committee for the International Symposia on Biological Reactive Intermediates, and organized and chaired numerous symposia for FASEB/EB, ASPET, ACS, and SOT. Dr. Monks has served on several NIH study sections, and numerous scientific and academic advisory boards. Dr. Monks also served on the AACP Research and Graduate Affairs Committee.

Goals for SOT: SOT must remain a vibrant and intellectually stimulating scientific organization. Such qualities are most frequently found in organizations that actively encourage diversity of opinions, such opinions typically reflecting the diversity of the organization’s membership. The Society is actively committed to diversity and the Membership Committee plays an integral role in this endeavor. Included in diversity efforts is diversity of scientific disciplines, as this also enriches the intellectual strength of the Society. Therefore my goal by serving on the Membership Committee is to assist the Society in its diversity efforts in all areas. In this regard, I consider my current and previous leadership experience will be of great benefit.


18

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: North Carolina Regional Chapter 2008–present; Molecular and Systems Biology Specialty Section 2008–present, Junior Councilor 2013–2014, Senior Councilor 2014–2015.

Experience: Joel Meyer has written a large number of SOT membership letters of recommendation.

Goals for SOT: I would like to see SOT play a larger role in promoting science literacy and science-based policy.

Joel N. Meyer BS, PhD

Employer Duke University


Education Duke University, PhD, 2003; Juniata College, BS, Environmental Studies/Peace and Conflict Studies, 1995.


19Membership Committee candidates continued on next page 4

Shaun D. McCullough MS, PhD

Employer US Environmental Protection Agency


Education University of Virginia, PhD, Biochemistry and Molecular Genetics, 2011; University of Virginia, MS, Biological and Physical Sciences, 2006; Clemson University, BS, Microbiology, 2004.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: CCT Organizing Committee for Building a Better Epithelium: Breaking the Barrier to the Next Generation of Toxicity Testing, Chair 2017–present; Career Resource and Development Committee 2016–present, Co-Chair 2017–present; CCT Organizing Committee for Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment, Chair 2015–2017; Mentoring Steering Group, 2017–present; North Carolina Regional Chapter 2013–present; Women in Toxicology Special Interest Group 2014–present; Inhalation and Respiratory Specialty Section 2013–present; In Vitro and Alternative Methods Specialty Section 2013–present; Mechanisms Specialty Section 2014–present; Molecular and Systems Biology Specialty Section 2013–present, Vice President-Elect 2016–2017, Vice President 2017–present; Gabriel L. Plaa Education Award 2015; Molecular Biology Specialty Section Postdoctoral Fellow Research Award 2014.

Experience: Dr. Shaun D. McCullough is a Principal Investigator in the National Health and Environmental Effects Research Laboratory of the US Environmental Protection Agency (US EPA) where he leads a research program that explores the molecular and epigenetic mechanisms of inter-individual variability in adverse health effects of inhaled toxicants using organotypic in vitro models and human clinical studies. Dr. McCullough also serves as the Task Leader for US EPA initiatives to develop concordance between in vitro and human in vivo toxicity testing.

After earning his PhD in Biochemistry and Molecular Genetics from the University of Virginia, Dr. McCullough completed his postdoctoral training in the US EPA’s Clinical Research Branch where he identified novel molecular pathways of single and multi-toxicant mediated stress and specific epigenetic markers that can be used to predict the cellular response to toxicant exposure. As a result of his postdoctoral work, he received the US EPA Superior Accomplishment Award, the Gabriel L. Plaa Education Award, the Molecular and Systems Biology Specialty Section Postdoctoral Fellow Research Award, and was featured in an article on postdoctoral fellows in the journal Science.

An active leader in the toxicology community, Dr. McCullough is on the Board of Directors for the American Society for Cellular and Computational Toxicology, a member of SOT’s Mentoring Steering Group, Co-Chair of the Career Resources and Development Committee, and Vice President of the Molecular and Systems Biology Specialty Section. Dr. McCullough has chaired several scientific sessions at SOT Annual Meetings, was the Chair of the recent Contemporary Concepts in Toxicology (CCT) meeting, “Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment,” and is the Chair of the upcoming CCT meeting “Building a Better Epithelium: Breaking the Barrier to the Next Generation of Toxicity Testing.” Dr. McCullough also is a regular peer-reviewer for a wide range of journals, including Toxicological Sciences, serves on the editorial boards of Environmental Epigenetics and the Journal of Toxicology and Environmental Health, and serves as a Subject Matter Expert in epigenetics and in vitro models for the US EPA review of guidance and policy documents.

Dr. McCullough plays an active role in science education as a member of the University of North Carolina at Chapel Hill’s Curriculum in Toxicology and mentor to trainees ranging from high school students to postdoctoral fellows, including a recipient of the 2017 SOT Pfizer Undergraduate Award and a 2017 Carl C. Smith Award winner. Dr. McCullough also engages his local community in toxicology as the Director and Co-Founder of “Tar Heel Tox Talks,” a public outreach partnership between the UNC Curriculum in Toxicology and the North Carolina Regional Chapter of SOT. Recently, Dr. McCullough led collaborations between SOT’s Molecular and Systems Biology Specialty Section and the Education Committee to develop a series of webinars designed to help undergraduate students succeed in their graduate school applications process.

Goals for SOT: The Society draws its strength from its membership’s engagement in cutting-edge science, commitment to a safer and healthier world, and investment in the development of future generations of toxicologists. Its success in these, as well as other, directions is driven by the disciplinary and demographic diversity of its membership. To continue expanding the impact of the field of toxicology and SOT in public health we must continue to expand our membership within traditionally toxicology-related fields as well as scientists whose interests and expertise will support the Society’s continued growth with new ideas, approaches, and applications in toxicology. If elected to the Membership Committee I will foster interactions between SOT and other societies and institutions to broaden the base of our membership across sectors, fields of study, and geographical regions.


20

Flemming R. Cassee PhD

Employer National Institute for Public Health and the Environment Netherlands


Education University of Utrecht, the Netherlands, PhD, Toxicology November, 1995.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Inhalation and Respiratory Specialty Section 2006–present, Councilor 2010–2012, Vice President-Elect 2014–2015, Vice President 2015–2016, President 2016–2017, Past President 2017–present; Nanotoxicology Specialty Section 2015–present, Vice President-Elect 2017–present.

Experience: Professor Flemming R. Cassee is an inhalation toxicologist at the Netherlands National Institute for Public Health and the Environment. In this position he is involved in research into adverse health effects from airborne nanomaterials and particulate matter (fine dust) and gaseous components (e.g., ozone, nitrogen dioxide) in the ambient air. In addition to this, Flemming Cassee is professor of inhalation toxicology at the Institute of Risk Assessment Sciences of the Utrecht University, the Netherlands. He is leading projects of multidisciplinary teams. These teams include amongst others toxicologists, epidemiologists, modellers and risk assessors. He has regularly published scientific reports and articles in international journals and presents research results at international conferences. Dr. Cassee is Senior Scientific Advisor to the Dutch Ministry of Infrastructure and the Environment, the Health Council of the Netherlands, World Health Organisation and the Organisation for Economic Co-operation and Development (OECD), and others. Furthermore, he is Editor-in-Chief of the journal Particle and Fibre Toxicology and a reviewer/editor of a number of other international scientific journals. He is member of the coordination team of the European Nanosafetycluster, overarching EU funded nanosafety projects. He has and still is participating in a number of these large integrated multimillion projects (e.g., NanoReg, NanoMile, Sun, NanoImpactNet, ENPRA, and PATROLS).

Goals for SOT: As the SOT is becoming more and more a society that attracts toxicologists from across the globe, my goal would be that this diversity is reflected in the various committees, special interest groups, and specialty sections. In addition, in an era where toxicology is under pressure as being the science that is seen as one that only tells the world about what is bad for the public and the environment, it is my goal to communicate the advantages of having access to toxicology very early in the development of a new chemical or other product that needs to reach the market based on the outcomes of risk assessment. Safe by design can only succeed if toxicologists are involved.


21

Antonio T. Baines BS, PhD

Employer North Carolina Central University


Education University of North Carolina at Chapel Hill, Postdoctoral Fellow, Pharmacology, 2006; University of Arizona, PhD, Pharmacology and Toxicology, 2001; Norfolk State University, BS, Biology, 1995.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Undergraduate Consortium Task Force 2017–present; Toxicologists of African Origin 2008–present, Councilor 2008–2010; Toxicologists of African Origin Legacy Award Mentor/Educator Award 2011; Undergraduate Educator Award 2016.

Experience: Dr. Baines’ first exposure to SOT started when he received the Undergraduate Travel Award to attend the Annual Meeting as a sophomore in college. It was this experience that sent him down a path that would lead him to participate in two summer research internships in toxicology under SOT Past President Dr. Glenn Sipes and eventually earn his doctorate in the field. Currently, as an Associate Professor and a biomedical scientist, Dr. Baines is very active in the Society and for the past 11 years has encouraged students to apply for the same undergraduate travel award that facilitated him in becoming a toxicologist. In addition, Dr. Baines regularly delivers the “Introduction to Toxicology” opening talk to undergraduates at the Undergraduate Program of the SOT Annual Meeting and serves on career panels. In 2016, Dr. Baines received the SOT Undergraduate Educator Award. This is an example of the commitment that Dr. Baines has for helping to produce the next generation of toxicologists.

Goals for SOT: Knowing how SOT helped me professionally during my years in college and graduate school, I would like to make sure SOT continues with this proud tradition in providing mentorship and professional development to undergraduate and graduate students. I believe this will help expand the membership of the Society. Also, I would like to make sure we do a better job recruiting students who usually do not attend SOT meetings. I believe exposure is important in making sure SOT recruits the best and the brightest, no matter where they are located across the country and world. Finally, I would like to help invite back our past members of SOT who may have left the Society for a number of reasons. I believe these past members have a wealth of knowledge that they can share with the younger generation of toxicologists. If elected to serve on the Membership Committee, I will do my best to help grow and broaden participation in SOT and maintain it as a premiere scientific organization for all interested in the advancement of human and environmental health.

Nominating Committee—From the Membership-at-Large (Vote for one of three)

22

Bob van de Water PhD

Employer Leiden University


Education Leiden University, PhD, Toxicology, 1995; Leiden University, MSc, Bio-Pharmaceutical Sciences, 1990; Leiden University, BSc, Bio-Pharmaceutical Sciences, 1988.

Experience: Bob van de Water has more than 25 years experience in mechanistic toxicological research. During his PhD he investigated mechanisms of renal toxicity using imaging approaches. In 1995, he received the SOT Colgate-Palmolive postdoctoral award to further the understanding of cellular stress responses in renal toxicity in the laboratory of Dr. James L. Stevens in Lake Placid, NY, USA. After his return to Leiden University in the Netherlands he applied molecular biology and mouse genetics to define the role of cell adhesion signaling in renal toxicity. Thereafter he has integrated transcriptomics and proteomics to define the signaling networks that drive adverse outcomes in relation to kidney and liver toxicity, as well as DNA damage responses. He also integrated RNA interference approaches to unravel signaling components that functionally determine cell demise after chemical exposure. More recently he has established fluorescent protein reporter cell models to determine the dynamics of most adaptive stress response signaling pathways using live cell high throughput microscopy. He has applied these novel approaches in the prediction of the liability for drug-induced liver injury. Currently he is the coordinator of the European Horizon2020 project EU-ToxRisk, that brings together 39 partners to drive a new paradigm on the application of new approach methods in chemical safety testing. Furthermore, he has been and is partner in three European Innovative Medicine Initiative projects: MIP-DILI, TransQST, and eTRANSAFE. He is currently the Chair of the division Drug Discovery and Safety of the Leiden Academic Centre for Drug Research with more than 50 scientific staff members. He has published more than 130 research papers and co-founder of OcellO, a spin-off company that provides services for image-based phenotypic high throughput drug discovery screening.

Goals for SOT: My aim is to contribute to the SOT in several ways. Firstly, I would aim to support the translation of basic mechanistic understanding of chemical adversity into practical applications. Further enhancement of our mechanistic understanding remains fundamental to toxicological sciences, this will require uptake of advanced technologies and state-of-the-art knowledge from other fields including for example the area of (cancer) cell biology. At the same time such fundamental novel insights should find its way into strategies and approaches that could facilitate the safety assessment for humans. Secondly, I want to promote the development and enhanced uptake of advanced human relevant model systems as alternative methodologies for chemical safety assessment. This should then facilitate the replacement and/or refinement of current safety testing strategies and could speed up the safety assessment of thousands of chemicals that so far have never been tested. Thirdly, I aim to bridge the toxicological sciences from both sides of the Atlantic and ensure the further exchange of our basic scientific knowledge and practical application in the area of safety sciences. My role as coordinator of a European flagship program on novel approaches and technologies for chemical safety testing will facilitate me to reach these goals.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Ad hoc TOX 90s Educational Issues Task Force, 1991, Chair, 1992–1994; Clinician-Scientist Engagement Task Force 2014–2015; Continuing Education Committee 2013–2016, Co-Chair 2014–2015, Chair 2015–2016; The Long Term Continuing Education (CE) Planning Task Force 2014–2016; Ohio Valley Regional Chapter, 2002–present, Vice President 1988–1989, President, 1989–1990, Past President 1991–1992, Councilor, 1992–1995; In Vitro and Alternative Methods Specialty Section, 1985–present; Mechanisms Specialty Section 1985–present, Secretary/Treasurer 2002–2004, Vice President-Elect 2006–2007, Vice President 2007–2008, President 2008–2009, Past President 2009–2010.

Experience: Marshall University 1986–present and Vice Dean for Basic Sciences 2016–present; Associate Editor Toxicology and Applied Pharmacology 1995–2001; Associate Editor Journal of Pharmacology and Experimental Therapeutics 2016–present; Editorial Board Toxicology 1994–present, Chemico-Biological Interactions 2011–present; Association of Medical School Pharmacology Chair, Secretary 2002–2004, President 2004–2007, Past President 2007–2009. He has more than 165 publications and his current areas of research focus are in renal toxicology and toxicogenetics.

Goals for SOT: The goal of the Nominating Committee is to find the best possible candidates to lead the Society of Toxicology. If elected, I will work to assure that this goal is accomplished.

Gary O. Rankin PhD

Employer Marshall University


Education University of Mississippi, PhD, Medicinal Chemistry, 1976; University of Arkansas at Little Rock, BS, Chemistry, 1972.

Nominating Committee—From the Membership-at-Large (Vote for one of three)

23

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Global Senior Scholar Exchange Program Scholar 2017.

Experience: Augustine Arukwe is a professor and molecular biologist/toxicologist at the Department of Biology, Norwegian University of Science and Technology (NTNU) Trondheim and European registered toxicologist. His experience and research has addressed and still addresses topics related to the functional and regulatory aspects of differentially expressed genes, proteins and enzymes, and the general stress of contaminants, including endocrine modulators in wildlife species and fish reproductive physiology. He received his doctor of science (DSc) degree from the University of Bergen in 1998, and has since then worked in the United States of America and in Canada. He was a member of the Scientific Steering Committee and panel member on Contaminants for Norwegian Scientific Committee for Food Safety. He has previously been a consultant for the United Nations University–International Network on Water, Environment and Health (UNU-INWEH) on a self-initiated project on environmental biomonitoring programme in Nigeria and capacity development for local scientists to sustain the monitoring. He has pioneered research on the development and validation of sensitive biomarkers of endocrine and chemical exposure in organisms (fish, marine birds, amphibians, and marine mammals). He has developed teaching and research tools into the molecular basis and mechanisms of toxicity and physiological responses with particular focus on differentially expressed genes whose functional products may modulate general health, fitness, growth and development in aquatic species, and the susceptibility/adaptation of these responses to climate change. He is extensively involved in several environmental toxicology capacity building projects in Nigeria, Tanzania, South Africa, and Vietnam.

Goals for SOT: Prof. Arukwe has broad research and administrative experience. He has broad international experience, having worked in North America, Africa, Asia, and Europe. His extensive involvement in several environmental toxicology capacity building projects in Nigeria, Tanzania, South Africa, and Vietnam will be a valuable asset in promoting the global initiative and agenda of SOT.

Augustine Arukwe BS, DSc

Employer Norwegian University of Science and Technology (NTNU) Trondheim


Education University of Bergen, Norway, DSc, Molecular Toxicology, 1998; University of Bergen, Norway, MSc, Environmental Toxicology, 1995; University of Bergen, Norway, BSc, Aquaculture, 1993.

Nominating Committee—From Regional Chapters (Vote for one of five)

24

Seema Somji PhDNorthland

Employer University of North Dakota


Education The George Washington University, PhD, Microbiology and Immunology, 1996; University of Karachi, Msc, Microbiology, 1986; St. Joseph’s College, Bsc, 1986.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Northland Regional Chapter 2002–present, Councilor 2016–present; Women in Toxicology Special Interest Group 2007–2016; Metals Specialty Section 2003–present.

Experience: Dr. Seema Somji received her PhD in Microbiology and Immunology from The George Washington University and did her postdoctoral fellowship at West Virginia University in Molecular Toxicology. She is currently an Associate Professor of Pathology at the University of North Dakota, School of Medicine and Health Sciences. Her research focus is in metal toxicology and carcinogenesis. She has been active in training undergraduates as well as graduate students in the area of Environmental Sciences. She directs a ten week summer workshop in Environmental Sciences, the goal being to provide research experiences to undergraduate students and develop a pipeline of talented undergraduates that advance to graduate level research careers in environmental health sciences. She also serves as a mentor to faculty in Primary Undergraduate Institutions and Tribal Colleges and Universities in the state of North Dakota. She currently serves on the editorial board of Toxicology Letters and Journal of Applied Toxicology.

Goals for SOT: My goal for the Society is to work with other members to identify candidates with both scientific as well as leadership skills that will further advance the strategic goals of the Society. I am also committed to increasing diversity in various committees of the Society.

Nominating Committee—Regional Chapters candidates continued on next page 4


25

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Mentoring Breakfast Planners 2016–2017; Regional Chapter Collaboration and Communication Committee 2016–2017; Lone Star Regional Chapter 2002–present, Councilor 2010–2013, Secretary 2013–2014, Vice President-Elect 2014–2015, Vice President 2015–2016, President 2016–2017, Past President 2017–present; Women in Toxicology Special Interest Group 2014–present; Risk Assessment Specialty Section 2003–present.

Experience: Dr. Plunkett is a pharmacologist, toxicologist, regulatory specialist, and principal of a consulting company known as Integrative Biostrategies LLC. Integrative Biostrategies, based in Houston, Texas, is a consulting firm that works at the interface of biological science, regulatory affairs and business decisions to provide its clients with science-based solutions to issues associated with product development and stewardship. During her consulting career, Dr. Plunkett has worked on a variety of projects dealing with the toxicology and human health risk assessment of chemicals and products regulated by agencies such as US EPA, CPSC, OSHA, US FDA, and USDA. This work has included projects on behalf of food companies, crop protection chemical manufacturers, and trade groups representing the food industry. She has expertise in pharmacokinetics and toxicokinetics, human health risk assessment, cardiovascular toxicology and physiology, neurotoxicology and physiology, and has done a great deal of work on children’s health issues. Dr. Plunkett is a Registered Patent Agent (USPTO No. 45,015) and works mainly with university-based inventors to obtain intellectual property rights and move their ideas from the laboratory to the marketplace. She is a part-time employee with Licata & Tyrell, PC, an intellectual property law firm based in Marlton, New Jersey.

Dr. Plunkett is board-certified as a Diplomate of the American Board of Toxicology, and a member of several professional organizations, including the Society of Toxicology, and American College of Toxicology, the Society for Risk Analysis, the Society for Neuroscience, and the American Association of Pharmaceutical Sciences. Dr. Plunkett has authored or co-authored 36 scientific publications, five book chapters, and has authored or co-authored abstracts for scientific meetings 50 times in her career. She has more than thirty years of experience in the areas of pharmacology and toxicology and has worked in both government and academic research. Dr. Plunkett received a BS degree in 1980 from the University of Georgia and a PhD in pharmacology from the University of Georgia, College of Pharmacy in 1984. From June 1984 through August 1986, Dr. Plunkett was a Pharmacology Research Associate Training (PRAT) fellow at the National Institute of General Medical Sciences, Bethesda, Maryland. From September 1986 to June 1989, Dr. Plunkett was an Assistant Professor of Pharmacology and Toxicology in the medical school at the University of Arkansas for Medical Sciences, where she performed basic research in the areas of neuropharmacology and toxicology as well as cardiovascular pharmacology and toxicology. Dr. Plunkett worked as a consultant with ENVIRON Corporation from 1989 through 1997.

During her academic research career, Dr. Plunkett received funding from the American Heart Association and the National Institutes of Health. During her consulting career, Dr. Plunkett’s work has been supported by contractual sources of funding, including the American Chemistry Council, industrial clients who manufacture pesticides and chemicals, and a variety of other companies such as food companies, pharmaceutical companies, and medical device companies. She has provided expert testimony on US FDA regulation of food products, human drugs, medical devices, and cosmetics.

Goals for SOT: If selected to serve on the Nominating Committee as a representative of the Regional Chapters, I hope to aid in the selection of nominees for officer positions that are well-qualified but also who provide the Society with leadership reflecting the growing diversity of the membership of our Society. SOT’s diversity is reflected in the variety of scientific disciplines of members involved in SOT, the number of members from countries outside of the United States, as well as the different work experiences of members involved in toxicological sciences (academics, industry, government, and non-governmental groups). With the importance of toxicology across many basic science disciplines, the growth of SOT is inevitable. The goal for nominating scientists to SOT leadership positions should be to embrace the diversity of the Society and to promote the role toxicology plays across scientific disciplines.

Laura M. Plunkett PhD, DABTLone Star

Employer Integrative Biostrategies LLC


Education University of Georgia, College of Pharmacy, Department of Pharmacology, PhD, 1984; University of Georgia, BS, Zoology, 1980.


26

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Allegheny-Erie Regional Chapter 2008–present, President-Elect 2011–2012, President 2012–2013, Past President 2013–2014, Councilor 2014–present; Cardiovascular Toxicology Specialty Section 2010–present, Vice President 2009–2011, Past President 2011–2012; Inhalation and Respiratory Toxicology Specialty Section 2009–present; Nanotoxicology Specialty Section 2008–present, Vice President-Elect 2015–2016, President 2016–2017, President 2017–present; Inhalation and Respiratory Specialty Section Young Investigator Award 2014.

Experience: Dr. Nurkiewicz is a Professor and Associate Chair for Research in the Department of Physiology, Pharmacology and Neuroscience at the West Virginia University School of Medicine. He also is the Director of the Toxicology Working Group, and Inhalation Facilities. Dr. Nurkiewicz’s research program has been active in the field of microvascular physiology and toxicology, with specific focus on pulmonary exposure to particulate matter and engineered nanomaterials for over a decade. His research program utilizes animal models of inhalation exposure and subsequent in vivo (intravital microscopy) and in vitro (isolated microvessel) techniques. Most recently, his research program initiated novel investigations in the field of maternal nanomaterial exposures and fetal microvascular ramifications. Dr. Nurkiewicz has been continuously funded by extramural agencies such as the National Institutes of Health (National Institute of Environmental Health Sciences) and Health Effects Institute since 2001. Dr. Nurkiewicz serves on the editorial boards of Nanotoxicology, Particle and Fibre Toxicology, and Reproductive Toxicology. He is an Associate Editor for Cardiovascular Toxicology, and Frontiers-Vascular Physiology, and an Ad Hoc reviewer for Toxicological Sciences. He is an Ad Hoc reviewer for various NIH study sections, including Systemic Injury by Environmental Exposure. Dr. Nurkiewicz has been an Adjunct Scientist at the National Institute for Occupational Safety and Health since 2008.

Goals for SOT: I am honored to be nominated for service on the national level; and for me, it is a special honor as toxicology was far from my original training. During the past seven years, it has been my pleasure to serve as the President of the Cardiovascular Toxicology Specialty Section, and then the President of the Allegheny-Erie Regional Chapter. Currently, I serve as the President of the Nanotoxicology Specialty Section. During these years and collective endeavors, I have found SOT to be consistently more devoted in every regard to the advancement of students, scientists, and research, than any other of my professional society affiliations. Certainly, my research program and trainees have benefitted tremendously during our years of SOT participation. It is to this end that I am committed to serve the Society. As a member of the Nominating Committee, it would be my pleasure to initiate and promote actions that: 1) attract and retain the next generation of toxicologists, 2) provide members with opportunities to expand the impact and scope of their research programs, and 3) advance the profile and influence of diverse SOT endeavors, in both national and international regards.

Tim R. Nurkiewicz PhDAllegheny-Erie

Employer West Virginia University


Education West Virginia University, PhD, Physiology, 1999; West Virginia University, MS, Exercise Physiology, 1992; Pennsylvania State University, BS, Exercise and Sport Science, 1990.

Nominating Committee—Regional Chapters candidates continued on next page 4


27

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Regional Chapter Collaboration and Communication Committee 2013–2015; South Central Regional Chapter 2012–present, Treasurer 2013–2015, Vice President 2015–2016, President 2016–2017, Past President 2017–present; American Association of Chinese in Toxicology Special Interest Group 2016.

Experience: As a Senior Research Biologist at the US FDA, Dr. Ning is responsible for leading a research team focused on toxicology and molecular pharmacology in the application of personalized medicine. He has designed, developed and established in silico, in vivo, in vitro and molecular approaches to evaluate genetic and epigenetic mechanisms for toxicological effects involving drug metabolizing enzymes and drug targeting enzymes. The results of his work provide an enhanced mechanistic understanding of drug toxicity and efficacy for US FDA reviewers. His research activities are highly integral to the US FDA’s mission and the Critical Path Initiative for personalized medicine. He participated in writing the US FDA Report (Blue Book) on “Paving the Way for Personalized Medicine.” Dr. Ning’s research efforts have resulted in 80+ peer-reviewed research articles or book chapters, which have been cited 4,000+ times. The scientific impact of Dr. Ning’s work also is reflected by his active collaborations with many colleagues, US FDA-wide, nationally and internationally on peer-reviewed research projects. Dr. Ning has received several US FDA Scientific Achievement Awards. Dr. Ning has served as the President of the South Central Chapter of Society of Toxicology, the President of Pharmacogenomics Group at the American Association of Pharmaceutical Scientists, and the Treasurer of the Massive Analysis and Quality Control Society. He has been an editorial member for five journals and a reviewer/judge for 50+ journals. He has organized/chaired US FDA-wide, regional, national, and international scientific conferences/sessions.

Goals for SOT: As an US FDA scientist, my goals and objectives for the SOT are to collaborate with SOT members to promote best practices associated with regulatory science and toxicology, and to pursue the opportunity to perform collaborative toxicological studies for the identification and characterization of toxicants associated with US FDA-regulated products, thus promoting public health. If elected, I will cooperate with the Nominating Committee and with other committee members to evaluate the candidates for elected office and elected committees.

Baitang Ning PhDSouth Central

Employer US Food and Drug Administration


Education University of Arkansas for Medical Sciences, PhD, Biochemistry, 2000; Sun Yat-sen University, MD, Biochemistry, 1986.


28

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Allegheny-Erie Regional Chapter 2014–2015; Southeastern Regional Chapter 2015–present, Councilor 2017–present; Food Safety Specialty Section 2014–2015; Medical Device and Combination Product Specialty Section 2014–present, Councilor 2016–present, Mentoring Subcommittee Chair 2016–present; Metals Specialty Section 2014–present; Regulatory and Safety Evaluation Specialty Section 2015–present; Risk Assessment Specialty Section 2014–present; MDCPSS Best Published Paper Regarding Medical Devices 2015 and 2017, Best Poster Presentation 2017.

Experience: Dr. Whitney Christian has more than 15 years of experience as a toxicologist and currently serves as a Managing Principal Toxicologist with Medtronic, Inc. in Jacksonville, FL, where he provides toxicology and risk assessment support across the business. Prior to joining Medtronic, he was a private consultant to Johnson & Johnson. Dr. Christian received a PhD in Molecular Toxicology from the Department of Environmental Medicine at the University of Rochester and a BA in Biology from Davidson College. Before graduate school, he conducted cancer research in the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill. He serves as a member of the Mutagenicity, Carcinogenicity, and Reproductive Toxicity Working Group (ISO/TC 194/WG 6) within the Association for the Advancement of Medical Instrumentation. He is a Full Member of the Society of Toxicology (SOT) and a member of the Metals, Risk Assessment, Regulatory and Safety Evaluation, and Medical Device and Combination Product Specialty Sections (MDCPSS). He serves as a Councilor for the MDCPSS as well as the Southeastern Regional Chapter of SOT. Dr. Christian is an author of numerous scientific articles and routinely speaks at national events. Some recent publications include The Use of Genetic Evidence to Defend Against Toxic Tort Claims—Part I (2017), Global Functions of Extracellular, Transmembrane and Cytoplasmic Domains of Organic Solute Transporter β Subunit (2017), An Exposure and Health Risk Assessment of Lead (Pb) in Lipstick (2015), and Correlation of Blood Cr(III) and Adverse Health Effects: Application of PBPK Modeling to Determine Non-Toxic Blood Concentrations (2014). Recent talks and presentations include Food Allergy in Medical Devices: Risk Assessment of Tropomyosin in Chitosan-Containing Products which won the Best MDCPSS Presentation Award at the 2017 SOT Annual Meeting, Medical Device Immunotoxicology: Modern Approaches and Special Cases for the 2016 Mid-Atlantic Society of Toxicology Spring webinar series, and Quantitative Risk Assessment of the Genotoxicity and Tumorigenicity of CoCr-Containing Hip Implants for the 2014 MDCPSS Fall webinar series. In addition, at the 2015 SOT Annual Meeting, Dr. Christian gave a seminar titled: Risk Assessment of Orthopedic Implants—Case Study of Metal-on-Metal Hip Prosthesis for the Advances in Safety Assessment of Medical Devices Continuing Education course. He also has received two awards for Best Published Paper Regarding Medical Devices for his research titled: Toxicology-Based Cancer Causation Analysis of CoCr-Containing Hip Implants: A Quantitative Assessment of Genotoxicity and Tumorigenicity Studies (2015) and A Preliminary Evaluation of Immune Stimulation Following Exposure to Metal Particles and Ions Using the Mouse Popliteal Lymph Node Assay (2017).

Goals for SOT: My goal is to nominate candidates that bring modern and innovative toxicology to SOT for the betterment of its diverse members. As a proponent of mentorship, I aim to nominate those willing to educate and influence future toxicologists.

Whitney V. Christian BS, MS, PhDSoutheastern

Employer Medtronic, Inc.


Education University of Rochester School of Medicine and Dentistry, PhD, Molecular Toxicology, 2012; University of Rochester School of Medicine and Dentistry, MS, Molecular Toxicology, 2010; University of Rochester School of Medicine and Dentistry, Environmental Medicine, 2007; University of North Carolina at Chapel Hill, Cancer Biology and Genetics, 2003; Davidson College, BS, Biology, 2001.

Nominating Committee—Specialty Sections candidates continued on next page 4

Nominating Committee—From Specialty Sections (Vote for two of nine )

29

SOT-Elected Positions: Nominating Committee, 2007–2009; Secretary-Elect 2011–2012; Secretary 2012–2014.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: ATSDR/NCEH/CDC Government Liaison Group 2011–2014; Committee on Diversity Initiatives 2002–2005 and 2014–2017, Chair 2003–2004, Ad Hoc Member 2004–2005, Co-Chair 2015–2016, Chair 2016–2017; Communications Committee 2012–2013; Communications Subcommittee: Editorial Board 2009–2011; Congressional Subcommittee Council Contact 2012–2013; Continuing Education Committee 1998–2001, Chair 1999–2000; Council Subcommittee on SOT Affiliates and Sponsors 2011; Education Committee 2002–2005, Chair, 2004–2005; Education Subcommittee for Minority Initiatives, 2001–2004, Chair, 2003–2004; Global Collaboration and Initiatives 2014–2016; Global Senior Scholar Exchange Program 2012; Historian Council Contact 2012–2014; Hookah Issue Statement Writing Team Writer and Chair 2014–2015; ICT Organizing Committee 2013–present; Issue Statement Review (ISR) Task Force 2013–2016, Co-Chair 2013–2014; K–12 Subcommittee Ad Hoc Member 2002–2005; Minority Subcommittee 2001–2002; NICHD Government Liaison Group Chair 2011–2014; Postdoctoral Assembly Executive Board Council Contact 2013–2014; Program Committee 1995–1998; Recognition Working Group 2011–2012; Research Funding Committee Council Contact 2013–2014; Specialty Section Collaboration and Communication Group Council Contact 2011–2014; Mid-Atlantic Regional Chapter 2002–present, Councilor 2001–2004, Vice President-Elect, 2006–2007, Vice President, 2007–2008, President, 2008–2009, Past President and Councilor 2009–2010; Women in Toxicology Special Interest Group 2004–present; Clinical and Translational Toxicology Specialty Section 2013–2016; Ethical, Legal, Forensics, and Social Issues Specialty Section 2016–present, Vice President 2016–2017, President 2017–present; Inhalation and Respiratory Specialty Section 1995–present, Councilor 2017–present; Immunotoxicology Specialty Section 1996–present, Secretary/Treasurer 1995–1997, Vice President-Elect 1997–1998, Vice President, 1998–1999, President 1999–2000, Past President 2000–2001; Metals Specialty Section 1997–2015, Vice President-Elect 2001–2002, Vice President 2002–2003, President 2003–2004, Past President 2004–2005, Program Committee Chair 2001–2004, Nominating Committee 2001–2004, Chair, 2001–2003, Vice President 2002–2003, President 2003–2004; Nanotoxicology Specialty Section 2013–2015; Reproductive and Developmental Toxicology Specialty Section 2007–present, Junior Councilor 2014–2015, Senior Councilor 2015–2016.

Experience: In addition to Dr. Zelikoff’s numerous roles in both appointed and elected SOT committees, she has chaired and continues to participate in SOT symposia, workshops, and CE courses. She currently serves on the Editorial Board of Environmental Health Perspectives and several other toxicology journals. In addition, she recently co-edited a book on metal toxicology and completed several chapters for Comprehensive Toxicology, Reference Module in Encyclopedia of Environmental Health and Immunotoxicity Testing. Dr. Zelikoff continues to actively participate in SOT and is currently President of the Ethical, Legal, Forensics, and Social Issues Specialty Section and Councilor of the Inhalation and Respiratory Specialty Section. She has extensive experience in an advisory and leadership capacity as reflected by her past/current membership on two NIH Study Sections including SIEE, National Academy of Science Panel, the National Toxicology Program (NTP Board Member) Scientific Advisory Board, a NASA Moon Dust Panel (Chair), United Nations Atmospheric Brown Cloud Human Health Effects Panel, and the New Jersey Department of Environmental Protection Human Health Committee. Dr. Zelikoff is heavily involved with students both in teaching (three graduate courses in toxicology and immunotoxicology) and in mentoring of masters, doctoral, and postdoctoral trainees in the area of developmental immunotoxicology of inhaled smoke mixtures and nanomaterials. In 2015, she was awarded the Mentoring Award from the Women in Toxicology Special Interest Group. In addition, as Director of Community Outreach and Engagement for the NYU Department of Environmental Medicine NIEHS Center, she leads a laboratory research mentorship program for high school and college students. Dr. Zelikoff has organized a number of international and national meetings in immunotoxicology, as well as developed immunotoxicology courses, in India, Thailand, New Zealand, and Australia. She was the keynote speaker for the inaugural meeting of the Slovenian Society of Toxicology as well as a speaker at several IUTOX meetings. Dr. Zelikoff’s level of professional involvement with SOT during the last 27 years makes her highly qualified for the Nominating Committee.

Dr. Zelikoff is a tenured professor in the Department of Environmental Medicine at the New York University School of Medicine. Her major research focus is developmental, immune and air pollution toxicology. Her current laboratory studies examine the developmental origins of disease associated with alternate tobacco products and particulate ambient air pollutants. She has more than 130 journal articles and book chapters in the area of toxicology and/or environmental health. In her role as the NYU NIEHS Community Outreach and Engagement Director, she has engaged with a variety of environmentally impacted communities associated with hydraulic fracturing, lead contamination in the water, and a Native American Tribal nation who reside on a Superfund site.

Goals for SOT: My goals for the next two years as a Nominating Committee member is to assure a slate of executives who are well balanced and possess the experience and drive to lead SOT and all of its members into the future. With world events raising many scientific challenges, it is important that our selected leaders be informed and prepared to serve as trail blazers.

Judith T. Zelikoff PhDInhalation and Respiratory

Employer

New York University School of Medicine


Education New York University School of Medicine, Department of Environmental Medicine, Postdoctoral Training, 1982–1984; University of Medicine and Dentistry of New Jersey (UMDNJ), PhD, Experimental Pathology, 1982; Farleigh Dickinson University, MS, Microbiology, 1976.


30

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Mid-Atlantic Regional Chapter 2006–present; Women in Toxicology Special Interest Group 2012–present; In Vitro and Alternative Methods Specialty Section 2012–present; Occupational and Public Health Specialty Section 2010–2014; Reproductive and Developmental Toxicology Specialty Section 2006–present.

Experience: Dr. Villano received her doctorate in Toxicology from the Joint Graduate Program in Toxicology (JGPT) at Rutgers University in 2007. She was then awarded a New Jersey Commission on Science and Technology postdoctoral fellowship which she completed at Phytomedics, Inc. from 2007–2009. She is currently a part of the Reproductive Toxicology Department at Bristol-Myers Squibb, where she oversees reproductive, developmental, juvenile, and investigative toxicology studies in support of large and small molecule development. In addition, she serves as a drug safety representative on various drug development teams. Dr. Villano is a Diplomate of the American Board of Toxicologist and a guest DART lecturer for the JGPT at Rutgers University.

Since joining the DART group at BMS, Dr. Villano has represented BMS to the ILSI-HESI Developmental and Reproductive Toxicology committee and served on the Education Committee for the Teratology Society. Presently, Dr. Villano serves as a councilor for the Middle Atlantic Reproductive and Teratology Association and has been involved in organizing annual meetings. She has been an active member of SOT since 2004.

Caren M. Villano PhD, DABTReproductive and Developmental

Employer Bristol-Myers Squibb Company


Education Rutgers University, PhD, Toxicology, 2007.

SOT-Elected Positions: Membership Committee 2009–2012, Chair 2011–2012.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Contemporary Concepts in Toxicology Conferences Committee 2017–present; FutureTox IV CCT Organizing Committee 2017–present; ToxSci Associate Editor 2014–present; Mountain West Regional Chapter Secretary 2000–2003; Pacific Northwest Regional Chapter 2002–present, Vice President-Elect, 2006–2007, Vice President, 2007–2008, President 2008–2009, Past President 2009–2010; Drug Discovery Toxicology Specialty Section 2006–2016; Molecular and Systems Biology Specialty Section 1998–present; Nanotoxicology Specialty Section 2007–present, Vice President-Elect 2014–2015, Vice President 2015–2016, President 2016–2017, Past President 2017–present; Neurotoxicology Specialty Section 2003–present; Reproductive and Developmental Specialty Section 2000–present.

Experience: Prior to entering graduate school, Dr. Tanguay worked at the City of Hope where he studied epigenetic mechanisms. As a graduate student, Dr. Tanguay focused on post-transcriptional regulation of gene expression. He received postdoctoral training in developmental toxicology at the University Wisconsin where he helped develop the zebrafish model for toxicological studies. A major goal of his research group is to identify the mechanisms by which chemicals modulate normal embryonic development and impact homeostasis and health.

Goals for SOT: Having served and participated in a number of SOT organizations and specialty sections during the past 17 years, I have focused on advancing the science and the mission of SOT. I would now like to do my part to ensure SOT remains relevant to stakeholders. I would also like to help increase the inclusivity and diversity of SOT membership.

Robert L. Tanguay PhDNanotoxicology

Employer Oregon State University


Education University of California, Riverside, PhD, Biochemistry, 1995; California State University, San Bernardino, BA, Biology, 1988.



31

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Education Subcommittee: Graduate Education 2017–present; Midwest Regional Chapter 2007; Ohio Valley Regional Chapter 2002–present, Councilor 2004–2006, Vice President 2006–2008, President-Elect 2008–2009, President 2009–2010, Past President 2010–2011; Women in Toxicology Special Interest Group 2003; In Vitro and Alternative Methods Specialty Section 2003; Mechanisms Specialty Section 1996–1998; Molecular and Systems Biology Specialty Section 1996–1998; Regulatory and Safety Evaluation Specialty Section 2014–present, Junior Councilor 2015–2016, Senior Councilor 2016–2017, Secretary/Treasurer 2017–present.

Experience: Dr. Roe has more than 20 years of experience as a practicing toxicologist in pharmaceutical and consumer product safety, through positions at both the US FDA (NCTR) and The Procter & Gamble Company. She has significant expertise in general, descriptive, and regulatory toxicology as well as special expertise in drug/xenobiotic metabolism. Her industry experience is quite broad and includes toxicology support of drugs, medical devices, herbal/dietary supplements, and water filtration devices. Dr. Roe is well-recognized externally as a toxicologist as evidenced by her service in several professional boards and committees including Executive Member (Secretary) of the American Board of Toxicology, United States Pharmacopeia Dietary Supplement Expert Committees (Co-Chair), Toxicology Forum, Chair of Scientific Programs Committee, Society of Toxicology Regulatory and Safety Evaluation Specialty Section Council (Secretary/Treasurer), SOT Education Subcommittee, and NIH/NCCIH Expert Advisory Panel to U54 Center Grant. She currently serves on the ADME Task Force of Cosmetics Europe, the Toxicology Working Group of Council for Responsible Nutrition, and has served on various working groups through the Consumer Health Products Association (CHPA). Dr. Roe is on the editorial board of Applied In Vitro Toxicology. She regulatory lectures in various toxicology topics as an Adjunct Assistant Professor position at the University of Cincinnati, Department of Environmental Health and Molecular Toxicology.

Goals for SOT: My primary goal as a member of the Nominating Committee is to recruit a slate of officers that will bring passion and experience to the various leadership positions within SOT.

Amy L. Roe PhD, DABTRegulatory and Safety Evaluation

Employer The Procter & Gamble Company


Education University of Kentucky, PhD, Toxicology, 1997; University of Alabama at Birmingham, MS, Biology, 1989; Central College, BA, Biology, 1987.


32

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Ohio Valley Regional Chapter 2012–2013; Association of Scientists of Indian Origin Special Interest Group 2011–2016; Women in Toxicology Special Interest Group 2015–present; Drug Discovery Toxicology Specialty Section 2016–present; Food Safety Specialty Section 2013–present, Vice President-Elect 2017–present, Councilor 2014–2016; In Vitro and Alternative Methods Specialty Section 2015–present; Inhalation and Respiratory Specialty Section 2011–2013; Mixtures Specialty Section 2013–present; Regulatory and Safety Evaluation Specialty Section 2014–present; Risk Assessment Specialty Section 2013–present; Frank C. Lu Food Safety Students Award 2014; Graduate Student Travel Support Award 2012; Harihara Mehendale Association of Scientists of Indian Origin Student Award 2013; The Ohio Valley SOT Battelle Minority/Women PhD Student Travel Award 2012.

Experience: Dr. Mansi Krishan is a Senior Scientific Program Manager at ILSI North America, where she provides scientific leadership to the research committees on food and chemical safety, and food packaging. Her primary responsibility includes working with scientists from government, academia and industry to identify emerging issues related to food safety and develop food safety programs to address the research gaps. Dr. Krishan has been actively engaged in food safety capacity building initiatives across the globe. She is leading a partnership with the United Nations Industrial Development Organization on behalf of ILSI North America and 16 global ILSI branches to develop harmonized food safety standards in the Arab region based on international best practices. Dr. Krishan received her doctoral degree in toxicology from University of Cincinnati in 2013. The focus of her doctoral research was to enhance intranasal delivery of nucleoside drugs to the central nervous system. She has authored/co-authored multiple peer-reviewed publications, a book chapter, and has been invited to co-edit a book on heavy metals in foods.

Dr. Krishan has been an active member of SOT since 2011 and continues to contribute towards SOT’s mission of “creating a safer and healthier world by advancing the science and increasing the impact of toxicology” through different venues such as scientific sessions, webinars, continuing education courses and training in toxicology. During her term as the Councilor of the SOT Food Safety Specialty Section (FSSS) from 2014–2016, she served as the Chair of the FSSS Awards Committee. Dr. Krishan has been instrumental in highlighting the impact of toxicology in food safety and increasing the visibility of the emerging FSSS within SOT. She developed the first webinar supported by the FSSS which led to a webinar series within FSSS, and has also developed successful scientific sessions on food safety which serve as a valuable educational resource to communicate the relevance of food safety and toxicology research to the scientific community. Dr. Krishan has been elected as the Vice President-Elect of the FSSS, 2017–2018. She has received multiple awards for her scientific contributions by prestigious professional societies including SOT, EUROTOX, American College of Toxicology (ACT), and Society of Toxicology, India (STOX). She also has been invited by reputed toxicology journals to peer review manuscripts, and has chaired/co-chaired scientific sessions at toxicology and food safety conferences. Dr. Krishan also has membership in the ACT, EUROTOX, International Association for Food Protection, Society for Risk Analysis, STOX, and Toxicology Forum.

Goals for SOT: My goal is to further strengthen SOT’s impact in the global scientific community by helping identify leaders in toxicology across the globe who are passionate about embracing the advances in science, and effectively communicating its impact to the scientific community and the public. SOT’s guiding principles: integrity, diversity, the drive for lifelong learning and commitment to improve public health, played a significant role in my growth as toxicologist and I live by these principles in both my personal and professional life. I will utilize my experiences and scientific collaborations in different sectors to identify nominees who share SOT’s core values and will work towards advancing the mission of the Society through their scientific leadership and commitment. I am honored to have been nominated for this role and look forward to your continued support.

Mansi Krishan PhDFood Safety

Employer ILSI North America


Education University of Cincinnati, PhD, Toxicology, 2013; Guru Gobind Singh Indraprastha University, Delhi, Bachelor of Technology, Biotechnology, 2009.



33

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Low-Level Arsenic Exposure Express Statement Reviewer 2016–2017; Organizing Committee for Toxicoepigenetics: The Interface of Epigenetics and Risk Assessment 2015–2017; North Carolina Regional Chapter 2010–present; Women in Toxicology Special Interest Group 2010–2012; Metals Specialty Section 2010–present, Secretary/Treasurer 2013–2015, Vice President-Elect 2015–2016, Vice President 2016–2017, President 2017–present; Mixtures Specialty Section 2012–2013; Nanotoxicology Specialty Section 2011; Reproductive and Developmental Toxicology Specialty Section 2012–2013; Stem Cells Specialty Section 2011–2012, Councilor 2010–2013.

Experience: Dr. Rebecca Fry, is a Professor and Associate Chair in the Department of Environmental Sciences and Engineering at the Gillings School of Global Public Health at UNC-Chapel Hill. Dr. Fry is the Principal Investigator of several large NIH-funded grants including a children’s cohort funded through the Environmental Influences on Child Health Outcomes (ECHO) program, an R01 from the NICHD and UNC’s Superfund Research Program. She is the Director of the Environmental Health Sciences training grant (T32) and Director of Graduate Studies in the Curriculum of Toxicology. Dr. Fry holds a PhD in biology with postdoctoral training in toxicogenomics and environmental health sciences. A primary goal of Dr. Fry’s research is to increase awareness of the deleterious impacts of toxic exposures during the prenatal period. Her research at UNC has identified epigenetic mechanisms that relate toxic substances to children’s health. She has served on the committee for the National Academies of Science (NAS) National Research Council for the IRIS review of inorganic arsenic, as a reviewer for the cancer and non-cancer risk assessment of arsenic in food by the US Food and Drug Administration (US FDA), and on the funding selection committee of the International Agency on Cancer Research (IARC).

Goals for SOT: I have three goals for SOT. First, it should be our goal to remain at the cutting-edge of the toxicology field. Second, we should continue to be a group of strong collaborators that have as a common mission understanding the biological mechanisms by which toxic substances are linked to disease. Finally, we should work together to identify innovative solutions to reduce the harms of substances in the environment.

Rebecca C. Fry PhDMetals

Employer University of North Carolina Chapel Hill


Education MIT, Postdoctoral Researcher, Toxicogenomics and Environmental Health Sciences; Tulane University, PhD, Biology, 2000; Tulane University, MS, Biology, 1997; William Smith College, BS, Biology, 1995.


34

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: CCT Organizing Committee for FutureTox III: Bridges for Translation 2014–2016; Communications Task Force 2004–2005; Scientific Liaison Coalition 2012–present; National Capital Area Regional Chapter 2009–2011; North Carolina 2002–present; In Vitro and Alternative Methods Specialty Section 2009–present, Vice President-Elect 2013–2014, Vice President 2014–2015, President 2015–2016, Past President 2016–2017; Neurotoxicology Specialty Section 2007–present; Regulatory and Safety Evaluation Specialty Section 2003; Reproductive and Developmental Toxicology Specialty Section 1996–1997; Risk Assessment Specialty Section 1998–present.

Experience: Dr. Fowle is an independent consultant in Pittsboro, North Carolina fostering the use of more efficient and informative approaches to toxicity testing and decision making. In 1979, he joined the US Environmental Protection Agency where he served in a variety of science and management positions, including Deputy Director of the Health Effects Division, Office of Pesticide Programs; Acting Director of the Neurotoxicology Division, National Health and Environmental Effects Laboratory, Deputy Director of the Science Advisory Board, Science Advisor to Senator Daniel Patrick Moynihan and Science Advisor to Congressman Albert D. Gore. Dr. Fowle has also held several other senior level advisory positions within US EPA’s Office of Research and Development. Dr. Fowle served on the Computational Toxicology Program Design and Implementation Team, and he led efforts to advance the use of alternatives to animal tests to inform decisions. Dr. Fowle also served as the official US EPA representative to the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), and as the Co-Chair of the OECD’s Validation Method Group for Non-Animal Testing. Upon his retirement he received US EPA’s Distinguished Career Service Award. Dr. Fowle has authored more than 30 journal articles and reports. He has been a member of the SOT since 1993. He served as a Councilor and Treasurer for the Society for Risk Analysis, and he currently serves as a Councilor for the American Society for Cellular and Computational Toxicology. He also is President of the Board of Trustees for the Evidence Based Toxicology Collaboration and as a Board member for the Center for Alternatives to Animal Tests at the Johns Hopkins University, and he serves as a member of the board of directors for the Institute for In Vitro Sciences, Gaithersburg, Maryland.

Goals for SOT: I am thrilled by the opportunity to stand for election to serve on the Nominating Committee for the Society. I am also humbled by this opportunity, because I recognize that science and its use to inform decisions concerning human health, environmental protection, and in promoting well-being are currently at a crossroads. While great advances are being made to improve toxicology through more efficient and informative approaches, the use of science in general to effectively inform decisions is being threatened, because a significant portion of society now questions the nature of truth and facts. SOT is poised to play a critical role in promoting the truth and integrity of the science of toxicology as we pass through this troubled time, and move to the future, but our success will be dependent on our ability to understand the nature of the challenges and our ability to engage in a way that is heard and valued. If elected my goals will be to work to identify and recruit a diverse set of candidates to meet these challenges in partnership with other societies, and who can serve as a resource to elected officials, to SOT members and to society at large in keeping with SOT’s mission “to create a safer and healthier world by advancing the science and increasing the impact of toxicology.”

John “Jack” R. Fowle, III PhD, DABTIn Vitro and Alternative Methods

Employer Science To Inform LLC


Education George Washington University, PhD, Biology/Genetics, 1980; George Washington University, BA, Zoology, 1971.



35

Joan M. Cranmer PhD, ATSNeurotoxicology

Employer University of Arkansas for Medical Sciences


Education University of Minnesota, PhD, Anatomy, Teratology, Pharmacology, 1971; Marquette University, BS, Biology, 1965; RPT, Physical Therapy, 1965.

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Neurotoxicology Specialty Section 1979–present; South Central Regional Chapter 2002–present, Co-Founder 2002; Women in Toxicology Special Interest Group 2001; Distinguished Neurotoxicologist Award from the Neurotoxicology Specialty Section 2008.

Experience: Dr. Joan M. Cranmer is Professor of Pediatrics and Toxicology at the University of Arkansas for Medical Sciences. Dr. (Spyker) Cranmer received her PhD from the University of Minnesota in 1971. She began her academic career at the University of Virginia as an Assistant Professor in 1972 and continued her pioneering research in behavioral teratology and toxicology for which she received a number of national awards including the National Health Foundation Achievement Award, Society for Crippled Children and Adults Merit Award, March of Dimes Basil O’Connor Research Award, and Joseph P. Kennedy Institute Award “for outstanding contributions to pediatric research.” In 1976, she was recruited to the University of Arkansas for Medical Sciences (UAMS) as Associate Professor of Pharmacology/Toxicology and Director of the Interdisciplinary Toxicology Graduate Training Program. In 1984, she was promoted to Professor of Pediatrics, and Pharmacology/Toxicology and joined the Core Group for KidTox, a pediatric toxicology program. Dr. Cranmer is Director, Office of Faculty Mentoring, Promotion and Tenure in the large (~300 faculty) UAMS Pediatrics department (1987–present). Dr. Cranmer has published more than 80 collaborative research papers dealing primarily with developmental neurotoxicology, long-term and delayed effects of prenatal or perinatal exposure to toxicants. Dr. Cranmer founded the journal NeuroToxicology in 1978, when the discipline was emerging, and served as Editor-in-Chief of NeuroToxicology for 38 years (1979–2017). Beginning in 1982, Dr. Cranmer initiated, organized, and obtained funding for 31 international conferences that brought together basic, clinical and applied researchers from around the world to discuss important topics and emerging themes in neurotoxicology. She ensured that these conferences provided a forum for mentoring, rewarding and promoting graduate students and postdoctoral fellows. In 2008, the Society of Toxicology/Neurotoxicology Specialty Section presented Dr. Joan Cranmer with the Distinguished Neurotoxicologist Award.

Dr. Cranmer’s selected national toxicology service experience includes: being a member of the National Institute of Environmental Health Sciences Advisory Council, NIH (2000–2005); NIH Division of Research Grants Toxicology Study Section (1975–1981); Advisory Committee, Techniques for Assessing Neurodevelopment in Children Exposed to Neurotoxicants, ATSDR (2002–2004); Board of Scientific Counselors Child Health Workgroup, ATSDR, DHHS/PHS, (1997–2003); Board of Directors, Children’s Environmental Health Network (1995–2005); Chair, Neuroscience Committee and Member, Science Advisory Board, Environmental Health Foundation (1995–1997); Superfund Science Advisory Board, NIEHS Basic Research Program, Akwasasne Mohawk Indian Nation PCB Superfund Site, SUNY and New York State Health Department (1992–2002); Science Advisory Board, Toxic Substances Subcommittee, US EPA (1980–1984); Behavioral Toxicology Committee, American Public Health Association (1977–1981); Environmental Research Assessment Committee, National Academy of Science (NAS)/National Research Council (NRC) (1975–1977); Committee on Evaluation of the Toxicity of Chemicals, WHO (1974–1976); Committee on US-USSR Joint Environmental Health Program, NIEHS/NIH (1972–1978); Committee on Principles of Protocols for Evaluating Chemicals in the Environment, NAS/NRC (1972–1974).

Goals for SOT: Through a variety of mechanisms and venues SOT organizes student focused activities and arranges for many research and travel awards for graduate students, postdoctoral fellows, and other young investigators among its membership. By providing an “international scientific home” and facilitating progress and success of the next generation of our SOT membership the Society leverages all of its missions. Throughout my professional career I have been passionately dedicated to supporting, mentoring, and promoting students and other young investigators and practitioners. My relatively focused goal for SOT is to work with other SOT members to enhance mentoring and networking for all students at every opportunity and find additional ways within the Society to do even more to recognize, reward, and promote our SOT rising stars and future leaders of toxicology.


36

Memberships, Chairs, and/or Offices held in SOT Committees, Regional Chapters, Special Interest Groups, Specialty Sections, formerly or currently, and SOT Awards: Northern California Regional Chapter 2002–present; Association of Scientists of Indian Origin Special Interest Group 2010–2016; Women in Toxicology Special Interest Group 2013–2016; Biological Modeling Specialty Section 2013–2015; Biotechnology Specialty Section 2010–present; Carcinogenesis Specialty Section 2011–present; Clinical and Translational Toxicology Specialty Section 2013–2015; Comparative and Veterinary Specialty Section 2010–2016; Drug Discovery Toxicology Specialty Section 2010–2016; In Vitro and Alternative Methods Specialty Section 2013–2015; Mechanisms Specialty Section 2011–2016; Molecular and Systems Biology Specialty Section 2011–2016; Regulatory and Safety Evaluation Specialty Section 2010–present; Reproductive and Developmental Toxicology Specialty Section 2013–2016; Toxicologic and Exploratory Pathology Specialty Section 2010–present.

Experience: Dr. Allamneni has more than 20 years of experience characterizing the nonclinical profile of small molecules and biologics in biopharmaceutical, environmental, chemical industry, including a decade of managerial/leadership and cross-functional team lead roles. She is an active member of the SOT since 2001 and serves on Scientific Proposal Review Committee—Women in Toxicology Special Interest group (2014) and the Carcinogenesis Specialty Section—Communications Committee (2015–present). Since joining ACT in 2006, she has fostered education and learning of young toxicologists by serving on its Program Committee (2011–2012, 2014–2016; 2017), Webinar Subcommittee of the Education Committee (2015–present), and Editorial Board of the International Journal of Toxicology (2011–present). Dr. Allamneni has authored/co-authored 20 peer-reviewed articles, including a book chapter, has been invited to deliver an online course, has presented her scientific work nationally and internationally, and served as a moderator/chair/liaison on several workshops/webinars/ symposia/panels.

Currently, Dr. Allamneni oversees nonclinical drug development of biopharmaceuticals as an Executive Director at Jazz Pharmaceuticals, Inc. Prior to joining Jazz in 2014, she held positions of increasing responsibilities at NGM Biopharmaceuticals, Inc., Genentech, Celera Genomics, Titan Pharmaceuticals Inc., Exponent, and ICF Consulting. She holds a DVM, an MS/PhD in Pharmacology/Toxicology (University of California-Davis), and a Pathology postdoctoral fellowship (Harvard Medical School). Dr. Allamneni is a Diplomate of the American Board of Toxicology (2002).

Goals for SOT: SOT is the largest professional society for toxicologists and its educational and outreach programs are driven by the time and thought that is invested by its elected officials. The vast talent pool of scientific leaders from all over the globe and from all industry sectors offers a rich opportunity to choose an elected Council that supports and promotes SOT’s vision, values, and strategic priorities. If selected as a member of the Nominating Committee, she will work hard to identify scientific leaders that uphold SOT principles, maintain the diversity of representation in all activities of the Society, and support lifelong learning and intellectual scientific stimulation, and above all those of high integrity.

Krishna P. Allamneni BVSc, MS, PhD, DABTBiotechnology

Employer Jazz Pharmaceuticals


Education Harvard Medical School, Pathology Postdoctoral Fellowship, 1998; University of California-Davis, MS/PhD, Pharmacology/Toxicology, 1997; Andhra Pradesh Agricultural University, DVM, 1993.

Ballot Facsimile Transmittal · Ballot Facsimile Transmittal ... SOT Ballot Clerk Company: Dembo...

Documents

Transcript of Ballot Facsimile Transmittal · Ballot Facsimile Transmittal ... SOT Ballot Clerk Company: Dembo...